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Bioactive compounds such as clotrimazole and resorcinol are important antimicrobial 
agents. Clotrimazole is effective against Candidiasis while Resorcinol is used in treating 
acne. Quantum chemical studies such as Density Functional Theory (DFT) and molecular 
docking are important tools in understanding the molecular properties of bioactive 
compounds most especially the mode of action by which they act as drugs. Understanding 
these properties would help in future drug development especially now that most microbes 
are developing resistance to already approved drugs.  Computational analysis and 
spectroscopic characterizations of clotrimazole, resorcinol, resorcinol -OD isotopomer, 
and resorcinol dianion salt were investigated. Infrared and Raman spectroscopic techniques 
were used for the structural characterization. Conformational analysis using potential 
energy surface scans via DFT was done for both clotrimazole and resorcinol. The 
energetically minimized forms and vibrational spectra were computed using ab initio and 
DFT quantum chemical techniques utilizing 6-311++G(d,p) basis sets. The unit cell of the 
room-temperature stable α-resorcinol and its –OD isotopomer were optimized at the 
B3LYP/6-311+G (d,p) level of theory and was shown to adopt a near Cs symmetry. 
Assignments of local vibrational modes associated with the crystal structure were also 
carried out. Relative stability analysis from the MP4 level, the syn-syn (S) form of 
resorcinol is predicted to be about 0.8 kcal/mol higher in energy than the most stable anti-
syn (AS) form. The out-of-plane vibrational modes of the solid sample exhibit some 
spectral shifts as compared to the gaseous phase as a result of the strong intermolecular 
packing forces. Molecular docking study exhibited that resorcinol is keratolytic active and 
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tends to form a stable complex in its near-AS form with Keratin-7. The conformational 
analysis of clotrimazole gave rise to three possible conformers. The geometrical parameters 
calculated at (B3LYP/6-311++G(d,p)) of the clotrimazole were in agreement with the XRD 
results. The calculated FMO energies gave insight into the molecular properties which 
disclosed that charge transfer occurs in the molecule and showed that the HOMO occurred 
on the imidazole ring while the LUMO occurred on the benzene rings. The MEP map 
showed that the negative region is localized in the imidazole ring and hence prone to 
electrophilic attack. The protein-ligand interaction of the title compound with Secreted 
Aspartic Proteinase 2 of C. albicans using molecular docking studies gave insight into its 





























 عبدالمجيب تلويس أوناوول             :االسم الكامل
 
 دراسة التحليل الطيفى وكيمياء الكم لمركبات كلوترايمازول والريسورسنيول          :عنوان الرسالة
 
 علوم الكيمياء               التخصص:
 
 2017مايو   :تاريخ الدرجة العلمية
 
نول هما من المركبات ذات الفاعلية الحيوية التي تلعب دوراُ مهما كعوامل متضادة الكلوترايمازول والريسورسي
الكلوترايمازول فعال ضد فطريات الجلد بينما الريسورسينول تكمن فعاليته في معالجة حب الشباب.  وتعتبر للميكروبات. 
كأدوات مهمة لمعرفة الخصائص الجزيئية  دراسات كيمياء الكم مثل نظرية الكثافة الوظيفية ونظرية اإللتحام الجزيئية 
لهذه المركبات ذات الفعالية الحيوية وباألحرى معرفة طريقة عملها كأدوية. معرفة خصائص هذه المركبات قد تمكن 
في المستقبل من تطوير االدوية خصوصا مع تطوير الميكروبات لمقاومتها ضد األدوية المسموح بها حاليا. تم تشخيص 
ترايمازول والريسورسينول والريسورسينول المتناظر باألضافة إلى الريسورسينول ثنائى الملح بواسطة مركبات الكلو
التحليل المحوسب والتوصيف الطيفى. وكذلك أستخدمت  تقنية مطيافية األشعة تحت الحمراء  ومطيافية رامان في 
ازول والريسورسينول أجرى بماسح طاقة السطح التوصيف التركيبى لهذه المركبات. تحليل التكوين الجزيئى للكلوترايم
الموضعية بأستخدام نظرية الكثافة الوظيفية. األطياف األهتزازية واالنماط المخترلة بالطاقة حوسبت بواسطة تقنيات 
 نظرية الكثافة الوظيفية وابانيشو بأستخدام                                            
 6- 311++G(d,p) basis sets  .  
  وحدة الخلية المثلي الستقرار الريسورسينول والريسورسينول المتماثل فى درجة حرارة الغرفة تم ضبطها بواسطة
  B3LYP/6-311+G (d,p) level of theory  والتي تتخذ عرض ذرات الكربون المتماثلة القريبة                           
  
ية المرتبطه بالشكل البلورى. تحليل االستقرارية النسبية من كما تم تحديد أنماط األهتزازات المحل
 مستوى                                           
و   MP4 and the syn-syn (S) form 
كيلو سعر لكل مول  له طاقة أكثر من 0.8للريسورسينول قدر بحواالى            
the most stable anti-syn (AS) form.
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هتزازات خارج السطح للعينة الصلبة أوضحت تغيرات طيفية مقارنة بالحالة الصلبة نتيجة لقوة الجزيئات البينية لقوي أنماط اال 
التعبئة. دراسة إلتحام الجزيئات أوضحت ان الريسورسينول نشط للقرنية وله ميل لتكوين مركب مستقر فى متشاكله اي اس  مع 
.       7-الكيراتين  
زيئ للكلوترايمازول اعطي ثالثة متشاكالت محتملة. تم حساب عوامل الشكل الهندسى على تحليل التكوين الج
 قاعدة                           
(B3LYP/6-311++G(d,p))      
بالنسبة  ى المحسوبةللكلوترايمازول والتى لها توافق مع نتائج حيود االشعة السينية. طاقات اوربتاالت جزيئات فيرم
جزيئية أوضحت حدوث إنتقال الشحنة فى الجزيئ وبناًء عليها فإن االوربتاالت الجزيئية الممتلئة العليا للخصائص ال
تحدث علي حلقة االميدازول بينما االوربتاالت الجزيئية الفارغة الدنيا تحدث علي حلقات البنزين. أوضحت خريطة ام 
الالقطة بالنسبة  -ة للهجوم االلكتروفيلى. تفاعل البروتيناي بي  إن المنطقة السالبة تقع على حلقة االميدازول نتيج
المستخلص من سى ألبيكان بإستخدام دراسات إلتحام الجزيئات  2-للمركبات موضوع الدراسة مع أسبارتك بروتينيز
اعطى نظرة فاحصة لطريقة عمل هذه المركبات لعالج فطريات 
                                                                                                                                 الجلد.   




1 CHAPTER 1 
INTRODUCTION 
Antimicrobial agents which are compounds that destroys microorganisms including fungi, 
bacteria and other microbes are often classified based on the microorganism they act upon. 
Clotrimazole acts on the fungus Candida albicans which is the pathogen for candidiasis[1] 
and hence it is called an antifungal while Resorcinol is active against Propionibacterium 
acnes the bacterium that causes  hidradenitis suppurativa (acne)[2], [3] hence, it is an 
antibacterial drug. Quantum chemical studies which includes Density Functional Theory 
(DFT) and Molecular docking have been widely used in studying bioactive compounds 
and classified under in silico methods [4] in drug discovery which is literally means in 
silicon referring to the silicon chips in computers.  
Designing drugs used to be a very expensive and cumbersome process. However, the 
advent of Computational Chemistry has proved a very useful tool in Medicinal Chemistry 
and in understanding the mechanisms by which drugs function. This information is 
important because it helps in the designing of new drugs [5]. Also Computer-Aided Drug 
Designing (CADD) has helped in reducing the cost in both time and money of drug 
development [6] Stereochemical behavior often influences the physicochemical properties 
of a compound [7]. For bioactive compounds, they have a particular influence on a 
molecule’s ability to interact with a protein target. Molecular docking involves predicting 
the most preferred conformation or orientation of a small molecule (bioactive compound) 
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when it bounds to a large molecule (protein). The way the small molecular binds to the 
protein can help predict the binding affinity and also the mode of action of that small 
molecule. Spectroscopy is also an important tool in drug design especially when it comes 
to characterization during drug delivery and drug formulation [8]. This is very important 
in how a drug is absorbed in the body. DFT complement the experimental spectra in 
assigning vibrational bands so as to distinguish the different functional groups present in 
bioactive compounds. Upon the application of molecular docking in understanding the 
mode of action of resorcinol and clotrimazole which are approved drugs. Molecular 
docking was applied in methimazole and ketoconazole and also newly synthesized 
piperazine and inorganic complex compounds which showed promise as anti-stress and 
anticancer agents respectively. 
1.1 Clotrimazole 
Clotrimazole (CTZ), 1-[(2-Chlorophenyl)(diphenyl)methyl]-1H-imidazole is a derivative 
of imidazole and is being used to treat fungal or yeast infections that affects the skin areas 
such as the feet (Athlete’s foot) and even the vagina. It is mainly used to treat candidiasis, 
a fungal disease, which is caused by the pathogen Candida albicans (C. albicans).  CTZ is 
applied as a cream on the affected areas of the skin or it is taken orally in tablet form. It is 
presumed that it inhibits the proteins in the fungal cell membrane which leads to the 
permeability of the membrane and ostensible disturbance of the enzymes bound to the 
membrane [9], [10]. C. albicans is an important agent of infection, which engages in a 
parasitic relationship with its host especially when the hosts have deficient immune system 
such as HIV/AIDS (Human Immuno-deficiency Virus/Acquired Immuno-deficiency 
Syndrome). Several studies have been directed on understanding the cell surface of C. 
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albicans mainly because of the two main functions of the cell surface which includes 
maintenance of the shape of the fungus acting as a permeable membrane and secondly, the 
interaction of the fungi with its external environment which include its host [11]. The latter 
part of the function of the cell surface highlights the reason why most research is on the 
cell surface of C. albicans. Candida albicans is the most common strain of Candida which 
is the pathogen for Candidiasis [12]. Over 150 species of Candida exist some of which 
include C. tropicalis, C. krusei and C. glabrata. Candida can be found in all humans. Their 
cell walls are thin and they are about 6 microns in length. They actually exhibit a 
commensal relationship in humans [13]. However, when they reproduction is in excess 
they become parasitic. The presence of virulent secreted aspartic proteases (SAPs) and 
other metabolites lead to a disruption in the energy cycle and hence fatigue in the host. 
Curd-like discharge from the vagina and white patches in the tongue area are a few 
symptoms of Candidiasis [14].  Anti-fungal agents such as CTZ and other Imidazole related 
compounds like fluconazole and ketoconazole are used in treating Candidiasis [15]. CTZ 
has been known to display its antimycotic activity by inhibiting the fungi cytochrome p450 
14α-lanosterol-demethylase (14-LD) commonly referred to as CYP51 [16]. This is done 
by restraining the biosynthesis of the sterol in particular the sterol auxotrophic strain 
including the demethylase [17]. This makes the membrane permeable and leads to a 
disruption between the enzymes and the membrane it bounds on. This action of CTZ 
prevents the further division and growth of C. albicans. However, there are speculations 
that CTZ may also interact with phospholipids and other proteins in the cell membrane of 
C. albicans [10]. Bilensoy et al [18]  and Robbe et al [19]  reported the experimentally 
observed IR and Raman spectra of CTZ respectively  while Dhudashi et al [20] used HPLC 
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method to estimate the CTZ in lotion and cream dosage form. Song and Shin [1] reported 
the XRD crystal structure of the title compound.  In this present work, the conformational 
analysis, molecular and spectroscopic properties including vibrational assignments have 
been reported which to the best of our knowledge has not been done till date. Molecular 
docking studies of CTZ with a virulent protein present in C. albicans using the possible 
conformations was also reported to give insight into the possible mode of action of CTZ in 
the cell membrane of C. albicans 
1.2 Resorcinol 
Resorcinol (1,3-dihydroxybenzene) is a fundamental organic compound that finds several 
applications in pure and applied fields of science [6,7]. Because of its pharmacological and 
biological importance, especially as a potent antibacterial agent [1], resorcinol remained a 
subject of extensive studies for its electronic ground and excited states from experimental 
and theoretical points of view.  Resorcinol is a simple chemical compound that has been in 
use for more than a century. Nevertheless, it is not widely known despite its many 
applications except among non-specialist in the field  of resorcinol chemistry [21], [22]. 
Resorcinol is a white crystalline solid which often exist in both α and β form which are 
both formed by the crystallization of resorcinol from ethanol and benzene respectively [21]. 
Resorcinol is a relatively less toxic compound compared to phenol [23]. Hence, its use in 
the pharmaceutical industry. It can easily be absorbed by the skin and causes irritation upon 
exposure to the eyes and during inhalation. However, it is stable under flammable 
conditions [24]. 2-methoxy resorcinol is a derivative of pyrogallol, a toxic natural product 
[25] mostly found in plants. However, its applications are found in supramolecular 
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photochemistry [26] and also has a uremic retention solute used in recognizing protein-
bound compounds [27]. 
Halogenated resorcinols are one of the most useful derivatives in resorcinol chemistry. 
They are formed via electrophilic aromatic substitution with the respective halogen atom. 
The presence of two hydroxyl groups cause higher activation, which consequently allows 
easy halogenation of resorcinol at the 2, 4 and 6 positions. Fluoro resorcinols are used in 
dye preparation, particularly fluorescein and rhodol dyes, 2-chloro resorcinol is a precursor  
in preparing 1,2-benzisoxazoloxy acetic acids, which is an antihypertensive drug while 4-
chloro resorcinol is used in preparing photoactive compounds which are applied in 
photolithography. Brominated and iodinated resorcinol compounds are used to alleviate 
the impact caused by fires and in radiology diagnosis respectively [22]. 
During the past decades resorcinol exhibited a number of medical applications, especially 
as it is used as a starting material to prodcue derivatives of Active Pharmaceutical 
Ingredients (API) for treating Alzheimer’s disease, sickle cell anemia and alcoholism [22]. 
However, resorcinol itself has been also used as a topical agent in treating dermatological 
diseases such as eczema, acne and Hidradenitis Suppurativa (HS) [29,30]. Molecular 
docking is a useful tool used in structure-based drug design (SBDD) to predict binding 
affinities of an API with specific protein targets [30] that play a role in the pathology of a 
disease. Resorcinol possess keratolytic properties and hence is known to target the 
follicular keratin plug which is the initiation stage of several HS lesions [29]. Therefore, a 
molecular docking analysis is useful to provide insights on the modes of action of 
resorcinol in treating HS.  
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2 CHAPTER 2 
LITERATURE REVIEW 
2.1 Clotrimazole 
3 Candida albicans is one of the popular fungal pathogens responsible for causing 
Candidiasis. It engages in a parasitic relationship with its host even though it initially 
engages in a commensal  relationship[11], [31]–[33]. This parasitic relationship is often  
worse when it occurs in that hosts have deficient immune systems, such as HIV/AIDS 
because they have T-cell deficiencies[11]. Though it is still unclear in mycology how the 
relationship changes from commensal to parasitic[31]. Candidiasis also particularly affects 
about 75% of the women population experience candidiasis in the form vulvovaginal 
candidiasis[34]. C.albicans are also known to play a role in early childhood caries which 
is the presence of decayed cavities in a child  of equal or less than 6 years of age [35]. Other 
fungal pathogens aside C. albicans that cause yeast infections include C. tropicalis and C. 
glabrata. However, C. albicans is the most renowned amongst them all [31].  Several 
studies have been directed at understanding the cell surface of C. albicans mainly because 
of the two main functions of the cell surface which include shape maintenance of the fungus 
and secondly, the interaction of the fungi with its external environment which include its 
host [11]. The latter part of the function of the cell surface highlights the reason why most 
research is focused on the cell surface of C. albicans.  The virulence attributes of C. 
albicans includes phenotypic switching, dimorphism,  hyphal formation and secretion of 
extracellular hydrolytic enzyme which includes aspartyl proteinases which are also called 
aspartic proteinases[36], [37].  
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4 Secreted Aspartic Proteinases (SAPs) are known to be located at the surface of the cell. 
They are encoded by a multigene family which is includes the presence of 10 SAP genes 
(SAP1-10)[38]–[42] which have been detected under many laboratory conditions[43]. 
Asides been among the virulence factors in Candidiasis, the activities of SAPs also 
contribute to tissue damage of the host, particularly SAP 1-3[44]. Removal of SAP1-6 have 
been suggested to assuage virulence in candidiasis keratitis [45]. Nevertheless, SAP1-10 
are contributing factors when it comes to vaginal candidiasis[46], [47]. The activities of 
SAP depend on pH, SAP1-3 are more active in lower pH(3-5) while SAP4-6 are more 
active at higher pH values (5-7)[32]. Though the normal pH of blood is neutral (7.4). 
However, the pH values vary through the body, such as the vagina area which is more 
acidic and the oral cavities which is neutral. Hence, the reasons why some SAP thrive more 
in certain areas of the body[32]. Since, SAPs plays a major role in many stages of infection 
of candidiasis, this makes it a potential drug target for treating Candidiasis infections[48], 
[49]. Pepstatin A has been used to inhibit SAPs[11]. However, there is need for new SAP 
inhibitors as there are new pathogenic fungal species, antifungal resistance, drug 
interactions and bioavailability amongst many other factors[48]. 
5 Azole based compounds alongside, polyenes are the most popular anti-fungal drugs used 
in treating candida infections[50]. However, polyenes have shown to be toxic hence the 
decrease in their use in treating candidiasis as compared to azole based compounds which 
are much safer[51].  Amphotericin B (AMB) is the most popular amongst the polyenes 
primarily because of the low occurrence of fungal resistance against it. However, it is 
nephrotoxic[50]. The known mode of action of  antifungal drugs is to target the cell wall 
or membranes of the pathogen[10]. Hence  the polyenes bind to ergosterol, the major sterol 
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of fungal membranes while the azoles inhibit of the fungal cytochrome P450-dependent 
lanosterol-14-α-demethylase which consequently leads to ergosterol reduction[16], [50], 
[51]. This action makes the membrane permeability and consequently leads to the 
disruption of enzyme systems bound to the membrane[52]. However, recent studies have 
shown that SAPs contribution to C.albicans virulence and hence are a potential drug 
target[31], [44], [53]. Many azole compounds have been designed over the years to 
improve the treatment of candidiasis. Ketoconazole proved to have superior in vivo activity 
and lower degree of inactivation after being absorbed as compared to other azole antifungal 
drugs such as clotrimazole[54]. Ketoconazole is also the only known antifungal drug to 
bind to the androgen receptor[55], [56]. Fluconazole and Itraconazole are also proven to 
be more effective than Clotrimazole and Nystatin(a polyene) when it comes to treating 
oropharyngeal candidiasis[57]. However, Clotrimazole has also shown to be successful in 
treating vaginal candidiasis as compared to the popular polyenes (AMB and Nystatin). 
Nevertheless a demerit of Clotrimazole is its side effect neurological  reactions and gastro-
intestinal troubles[58]. Itraconazole is very active against mucosal form of candidiasis and 
it is quite similar to Fluconazole with respect to its activity. However, the latter has 
different pharmacological properties  and does not violate any of the Lipinski’s rule of five 
(RO5)[59], [60] alongside voriconazole[61], [62]. Azole based compounds have also 
recently been applied in  corrosion inhibition[63] and Surface Enhanced Raman 
Spectroscopy (SERS)[64], [65]. 
2.2 Resorcinol  
Resorcinol (1,3-dihydroxybenzene) is an important building block in organic synthesis 
and finds several applications in pure and applied fields of science [66], [67]. Because of 
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its pharmacological and biological importance, in particular its use as a potent antibacterial 
agent [68], resorcinol has been a subject of extensive interest both from experimental and 
theoretical points of view [22]. In the solid and gas phases, three possible rotamers of 

































Anti (A) Anti-Syn (AS) Syn (S)  
Scheme 1. Atom numbering and the three possible rotamers of resorcinol 
In case of solid-phase resorcinol, intermolecular interactions are stronger, which is due to solid 
packing arrangement. Based on x-ray crystallographic analysis, resorcinol exists in two forms 
i.e., α- and β-resorcinol. The crystal structure of α-resorcinol, the stable form at the room 
temperature and atmospheric pressure, was first reported by Robertson [69]. The study 
revealed that molecules in α-resorcinol maintain the anti-configuration (A) of C2v symmetry 
[69]. The crystal phase structure of α-resorcinol is stabilized by intermolecular hydrogen 
bonding with a distance in the order of 2.7 Å.  Two years later, the crystal structure of β-
resorcinol, which arose due to phase change  at 347 K, was also disclosed [70]. In the case of 
β-resorcinol, the molecular conformation interconverts into the Cs anti-syn (AS) 
configuration. β-Resorcinol was shown to have a denser phase with a nearly 3% volume 
contraction [70]. In both systems (α & β-resorcinols), the unit cell contains four resorcinol 
molecules with different molecular packing and lattice parameters [22], [69]. Raman 
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spectroscopy has been used to characterize the α to β phase change and study different nature 
of intermolecular hydrogen bonding networking as the resorcinol changes from one 
crystalline phase to another [70], [71].  
Moreover, studying the properties of the three possible rotamers of resorcinol in the 
gas phase has been of great interest. In previously reported spectroscopic studies, anti-syn 
(AS) and anti (A) rotamers were readily identified due to their comparable stabilities. The 
free-jet spectrum of resorcinol with only a single origin in the near-UV region was first 
disclosed in 1950 [72]. This was followed by a report by Dunn et al [72] on high-resolution 
laser resonant two-photon ionization (R2PI) spectra of resorcinol, which permitted the 
identification of three distinct rotamers of the compound. The resonance-enhanced 
multiphoton ionization (REMPI) and hole-burning (HB) spectra of resorcinol were also 
recorded by Gerhards et al [73] wherein both AS and A rotamers were identified. In 1996, 
Melandri et al [74] confirmed the coexistence of the three configurations of the compound in 
the gas phase by free-jet millimeter wave (MW) spectrum [75]. The study revealed that A and 
AS forms possess relatively similar stability whereas the S form lies at least 400 cm-1 higher 
in energy. The careful assignments of the vibronic states in the dispersed fluorescence (DF) 
spectra of resorcinol confirmed the presence of the more stable A and AS forms although 
there was a little variance in the spectral features between the two rotamers [76]. Moreover, 
the A and AS rotamers of resorcinol and its deuterated analogs in their S0 and S1 electronic 
states were also confirmed by the high-resolution UV spectroscopy [75]. However, the study 
did not cover investigation of the S rotamer. In the same study [75], automated assignments 
have been performed using a genetic algorithm approach with an asymmetric rotor 
Hamiltonian. Later, Gerhards et al [76] have reported the mass analyzed threshold ionization 
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(MATI) and infra-red photo induced Rydberg ionization (IR-PIRI) spectra of resorcinol and 
its cationic species wherein they observed the A and AS conformers of the compound 
(Claudio and Ha, 1990; Gerhards et al., 1998). Thus, it can be concluded that the AS and A 
forms of resorcinol are more stable in the gas phase compared to the S form. These findings 
were further supplemented by theoretical calculations together with some of the 
aforementioned structural and conformational spectroscopic investigations [76]–[78] 
Additional computational studies on the energetics and structural properties of resorcinol have 
also been reported [77]. The predicted energy differences between the three isomers (AS, A 
and S) of resorcinol at the HF/4-31G* level was found to be smaller (0, 84 and 378 cm-l, 
respectively) with a rotational barrier around the C-OH bond in the order of 2-3 kcal/mol [78]. 
Computational studies have been extended to the crystal phase of resorcinol. The crystal 
morphology and solvent effect on the crystal habit of resorcinol and other organic systems by 
ab initio calculations were studied [79]. Moreover, the stability and lattice parameters of the 
two crystalline phases of resorcinol were explored by molecular dynamics calculations in an 
NPT ensemble [80], showing good agreement between the predicted properties and 
experimental data earlier reported. Moreover, theoretical methods have been employed to 
understand the nature of interaction between resorcinol and different solvents [81]–[83]. 
Blanco et al have explained the overlapping pKa values of resorcinol determined by UV-Vis 
spectroscopic techniques with the help of HF and DFT-B3LYP calculations [84]. The 
theoretical data enabled to explore the molecular conformations and solute–solvent 
interactions of the resorcinate anions. Moreover, B3LYP method was employed [85] to 
interpret the solvation effect by predicting total energies, dipole moments, reactivity 
parameters and transition states involved in resorcinol-solvent species. A theoretical 
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resorcinol-water model of 1:2 stoichiometry was investigated to explain the high dipole 
moment (8.6 D) of resorcinol in water [85].  
The assignments of the vibrational modes of resorcinol in crystal and gaseous 
phases by a number of spectroscopic techniques were also carried out, which provided 
deeper understanding of the electronic and rotameric nature of resorcinol. The vibrational 
assignments based on its infrared and Raman spectra in the solid phase were first reported 
by Penot et al [81] and Hidalgo et al [82]. Later on, a number of these assignments were 
revised by Green et al [83].  The gas-phase infrared spectrum of resorcinol in the range 
4000-625 cm-1 at 190°C was recorded by Wilson [86]. Detailed assignments of the IR 
bands revealed that the single molecule adopts a Cs symmetry structure that corresponds to 
the AS rotamer. In a recent gas-phase study [87], the analysis of the vibrational states by 
the dispersed fluorescence (DF) spectrum of resorcinol in the free jet revealed the 
coexistence of AS and A rotamers. Moreover, the polarized infrared spectrum of α-
resorcinol crystals in the lattice mode and internal vibration regions at lower temperatures 
have been reported [88]. Particularly, O-H stretching frequencies have been investigated 
by means of infrared photo induced Rydberg ionization (IR-PIRI) [89] and non-resonant 
ionization detected (NID) infrared and near-infrared (IR-NIR) spectroscopic techniques 
[78]. The assignments of the νOH stretching overtones of resorcinol clearly confirmed the 
existence of the two nonequivalent O-H bonds associated with the AS rotamer. In addition, 
the other two rotamers could also be assigned in the overtone spectra with the help of 




Herein, we wish to report our study based on extensive vibrational frequency 
calculations based on both the single molecule and unit-cell system of crystalline resorcinol. 
The infrared, Raman and 1H NMR analyses of resorcinol-OD and resorcinol dianion salt 
have also been performed and compared with the resorcinol. The conformation of 
resorcinol has been explored at different calculation levels for a more accurate energetic 
















6 CHAPTER 3 
METHODOLOGY 
3.1 Experimental Details 
The studied of clotrimazole and resorcinol were purchased from Sigma Aldrich and used 
without any additional refinement for spectroscopic analyses. The mid-infrared spectra 
(4000-400 cm-1) were collected at room temperature using a Nicolet 6700 FT-IR 
spectrometer equipped with a globar source, a KBr beam splitter, and a DTGS KBr detector 
at one-wavenumber resolution using a KBr window. The Nicolet 6700NXR FT-Raman 
module equipped with a CaF2 beam-splitter and an InGaAs detector was used to collect 
the Raman spectra (4000-100 cm-1) of the three compounds at room temperature. The He-
Ne laser source operating at 1064nm with 0.2 W was used for sample excitation.  
3.2 Computational Details 
All the computational calculations of the studied molecules were done with the Gaussian 
09 program [90] using the Density Functional Theory.  The molecules were optimized at  
the B3LYP method using the 6-311++G(d,p) as the basis set. The vibrational frequencies 
were calculated for all the studied molecules and no imaginary frequencies were present. 
The VEDA program [91] alongside GaussView [92] were used to assign the vibrations of 
all the molecules. The frequencies calculated were scaled to have a reasonable comparison 
with the experimentally determined ones using the method developed by Saadi and Laane 
[93]. Frequencies within the range of 2700 cm-1 and 4000 cm-1 used a scaling factor of 
0.961 while those within the range of 0 to 1800 cm-1 used 0.985 as the scaling factor.  The 
proteins structures were downloaded from the protein data bank (PDB) [94] and were 
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validates using Ramachandran plots via the Moleman 2 program [95]. All the  molecular 
docking studies were calculates using the CLC drug discovery workbench 3.0.2 [96]and 























7 CHAPTER 4 
RESULTS AND CONCLUSION 
4.1 Clotrimazole 
4.1.1 Molecular structure 
CTZ is a non-planar compound that contains 4 ring structures which include two benzene 
rings, a chlorobenzene and an imidazole ring. The four rings are connected by a quaternary 
carbon   at the center as seen in Fig.1 which gave the structure a C1 symmetry point group. 
Song and Shin [1] had described the crystal structure of CTZ. The Potential Energy Surface 
(PES) Scans depicted in Figs 5 and 6 showed rotations around the C6-C7 and C7-N10 bonds 
respectively. The PES resulted in four energy conformations; A B and C (Fig. 2). It was 
observed that CTZ had low stability whenever the chlorine atom was close to any of the 
aromatic rings as seen in conformers A and C (Figs. 3 and 4). This might be due to steric 
crowding which also involves the repulsion between the negative electrons of the chlorine 
atom and the pi-electrons present in the aromatic rings and hence the most stable structure 
conformation occurred when the rings where most far apart (conformer B) to minimize 
repulsion. The energy difference between the most stable conformer and the least unstable 
conformers is about 5kcal/mol.  In the first PES scan (Fig. 3) which has C6-C7 has its rotational 
bond, it was observed that the chlorobenzene moved about 180° from conformers A to B. The 
relative energy difference was about 5kcal/mol though the energy. However, in the second 
PES scan (Fig. 4) which has its rotational bond at C7-N10, it was observed that a 180° flip in 
the imidazole ring from conformer A led to a lower energy conformer C which had a relative 
energy difference of less than 1kcal/mol. The PES was also carried out in aqueous phase and 
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the results showed the same conformations as in gas phase except that the energies were 
slightly higher (Table 1). Hence, CTZ is less stable in aqueous phase than in gas phase. The 
PES revealed Conformer B has the most stable while conformer A and C had similar 
stabilities. Conformer B’s stability is due to the absence of steric crowding and repulsive effect 









































































Figure 3. Potential energy scan resulting from the rotation about the C1–C6–C7–N10 bond 
















Figure 4. Potential energy scan resulting from the rotation about the C6–C7–N10-C25 bond 









Table 1. The relative energies from the three possible conformers of clotrimazole in gas 















4.1.2 Geometrical parameters 
The bond angle and bond distances of the chlorobenzene and imidazole ring were used as 
the selected parameters in CTZ and were compared to other reported works. The bond 
length of the chlorobenzene ring (Table 2) showed a good agreement between the XRD [1] 
and the DFT. The C11-C1 which is the longest bond length was 1.743 and 1.764 for both 
XRD and DFT respectively. This was also in agreement to the single molecule of 
chlorobenzene which was determined experimentally to be 1.725 by Roussy et al [98] and 
theoretically calculated to be 1.762 [99], though at a lower basis set of 6-311G* as 
compared to the 6-311++G(d,p) basis set used in this work. The bond angle C2-C1-Cl11 was 
depicted to be 116° and 115.4° for the XRD and DFT respectively and this was lower 
compared to the single chlorobenzene molecule which was 119.801° and 119.308° for both 
the experimentally observed [98] and DFT calculated [99] respectively. The difference in 
bond angle is possibly due to the orientation of the chlorine atom to minimize the steric 
crowding due to the presence of the other three aromatic rings present in the title 
compound. For the imidazole ring, the DFT calculated bond lengths were slight higher than 
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the XRD. However, there was a very good agreement between N12-C24 and N12-C25 which 
were 1.372 and 1.315 respectively for the XRD and 1.375 and 1.314 for the DFT calculated. 
This also concurred to the experimental data [100] of single imidazole molecule and 
theoretically calculated [99] (though at a lower basis set of 6-311G**) which gave 1.314 
and 1.312 respectively for N12-C25. The bond angles N10-C23-C24 and N10-C25-N12 had a 
perfect agreement in both the XRD and DFT of 106.1° for the former and a very good 
agreement of 112.5° and 112.3° for the latter respectively. This also concurred to the single 



















Table 2. Some selected structural parameters of clotrimazole calculated using 
DFT/B3LYP at the 6311++G(d,p) basis set with XRD data. 
Label XRD DFT 
Bond length (Å)   
Cl11-C1 1.743 (2) 1.764 
C1-C2 1.381 (3) 1.394 
C1-C6 1.400 (3) 1.409 
C2-C3 1.375 (3) 1.390 
C3-C4 1.373 (4) 1.389 
C4- C5 1.386 (3) 1.392 
C5-C6 1.390 (3) 1.402 
C6-C7 1.552 (3) 1.558 
C7-N10 1.498 (2) 1.500 
N10-C23 1.371 (3) 1.388 
C23-C24 1.345 (3) 1.368 
N12-C24 1.372 (3) 1.375 
N12-C25 1.315 (3) 1.314 
N10-C25 1.356 (3) 1.376 
Bond Angle (°)   
C2-C1-Cl11 116.0 (2) 115.4 
C6-C1-Cl11 122.1 (2) 122.7 
C2-C1-C6 121.9 (2) 121.9 
C3-C2-C1 120.0 (2) 120.3 
C3-C4-C5 120.0 (2) 120.0 
C4-C5-C6 121.8 (2) 122.5 
C6-C7-N10 106.7 (2) 109.6 
N10-C23-C24 106.1(2) 106.1 
C24-N12-C25 104.1 (2) 105.5 








4.1.3 IR and Raman Spectra 
The experimental Raman and IR bands (Figs 5 and 6) along with the calculated wavenumbers 
are depicted in Table 3. The wavenumbers were scaled using a factor of 0.961 for frequencies 
greater than 2700 cm-1 and 0.985 for frequencies less than 1800 cm
-1 [93].. CTZ has 42 atoms 
and hence using the 3N-6 formula for the degree of freedom for a non-linear molecule, where 
N is the number of atoms it has 120 vibrational modes. The peak at 3302cm-1 are -CH stretch 
vibrations. This is because the vibration is symmetric and hence has a low activity in IR 
spectroscopy whereas it is highly active in Raman spectroscopy. The imidazole ring in CTZ 
has no N-H vibrations since the first Nitrogen atom is bonded to the quaternary carbon while 
the other is contributing to the aromaticity of the ring. The C-N stretch has been 
experimentally reported in imidazole to be in 1325 cm-1 to 1486 cm-1 [101] whereas it is 
observed to be in be at 1478 cm-1 and calculated to be at 1476 cm-1. The difference in frequency 
is probably because of the quaternary carbon attached to the Nitrogen atom. The imidazole  
ring deformation was reported by Ramasamy to be at 891 cm-1 and 899 cm-1 for observed and 
calculated respectively [101]. However, in CTZ the imidazole ring deformation was seen at 
883 cm-1 and 901 cm-1 for both observed and calculated respectively. The C-H stretch has 
been reported to  be in the range of 3001-3091 cm-1 for Toluene [102]. Nevertheless, in CTZ 
the range is 3040- 3173cm-1 for the two benzene rings. However, at both 1156 cm-1 and 1145 
cm-1 for both observed and calculated respectively, a C-H ring stretch is common to the three 
benzene derivatives simultaneously.  The C-C ring stretch in Toluene is stated to be 1487-
1624 cm-1 [102] while in CTZ it is observed to be in 1472- 1613 cm-1 for the two benzene 
rings. The chlorobenzene ring is responsible for the frequency observed at 1617 cm-1. The ring 
deformation for the two benzene rings occurs at  1001 and 1002 cm-1  for both observed and 
calculated respectively this is much lower compared to what was reported for by Ramasamy 
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et al for Toluene [102] which occurs at 1032 and 1042 cm-1 for both observed and calculated 
respectively. The frequency seen at 1036 cm -1 is exclusively for the ring deformation of 
chlorobenzene. The Cl-C stretch was seen at 438, 434 and 447 cm-1 for the calculated, and 















































Table 3. Calculated and observed infrared, Raman frequencies (cm-1), and vibrational 
assignments for clotrimazole 












A 3173.526 3.838 59.939 3164 3166 97% CH sym str 
A 3134.548 0.611 33.010 - - 99% CH sym str 
A 3111.337 6.139 
143.66
6 
3110 3112 97% CH sym str 
A 3093.172 0.829 
136.96
6 
- - 82% CH sym str 
A 3092.989 4.926 66.043 - - 80% CH sym str 
A 3089.065 3.137 89.999 3082 - 95% CH sym str 
A 3077.598 4.010 
174.61
6 


























62.008 - - 45% CH sym str 
A 3051.101 2.266 66.999 - - 53% CH sym str 
A 3050.147 8.484 
129.13
9 
- - 44% CH sym str 
A 3048.924 5.964 
116.97
4 
- 3049 45% CH sym str 
A 3041.044 0.119 41.838 - - 38% CH sym str 
A 3040.535 0.373 46.689 - - 34% CH sym str 
A 1617.597 1.953 20.880 1627 - 28% ring breadth 
A 1613.609 4.862 33.103 - - 21% sym ring str 
A 1603.927 3.146 24.747 - - 24% sym ring str  
A 1599.329 1.206 20.310 - - 20% sym ring str 
A 1595.778 0.236 9.615 - - 19% sym ring str  




5.767 -  
24% N-C str; 18% 
CH bend 


















1.090 - - 13% ring breath 




0.399 1436 - 12% ring breath 
A 1355.133 0.689 20.136 - 1351 47% N-C str 
A 1344.594 0.538 1.117 1349 - 22% sym ring str 
A 1338.681 0.551 1.690 1326 1336 23% sym ring str 
A 1310.377 6.833 1.619 - 1306 12% asym ring str  




8.168 - - 11% N-C str  
A 1283.454 5.075 4.414 - - 13% asym ring str  
A 1277.552 6.888 1.751 1276 - 33% asym ring str  








11.467 - - 19% ring breath  
A 1196.513 4.229 6.977 - 1193 18% CH asym bend 
A 1181.188 6.142 12.480 - 1188 
15% CC sym str; 
24% CH asym. bend 
A 1174.707 7.087 4.496 1171 1171 
15% CC sym bend; 
21% -CH asym bend 
A 1167.151 0.552 2.284 - - 29% CH asym bend 
A 1166.798 0.042 3.082 - - 33% CH asym bend 
A 1164.270 4.799 3.474 - 1166 
17% CC sym str; 
13% CH asym bend 
A 1145.774 8.530 43.027 - 1156 
15% ring breath; 
17% CH asym bend; 
18% CC sym str 
A 1134.455 7.451 3.361 - - 
18% ring breath; 




3.391 1114 1114 
45% N-C str; 31% 
CH asym bend 
A 1099.413 1.882 0.481 - - 11% ring breath 




18.154 1081 1080 
13% ring breath; 
48% CH asym bend 
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A 1060.069 3.551 27.990 - - 
32% ring breath; 
20% CC sym str; 




5.835 1039 - 15% ring breath 
A 1038.514 1.952 65.053 - - 
16% ring breath; 




19.195 - - 
14% Cl-C sym str; 
28% ring def 
A 1016.050 4.811 6.504 - - 34% N-C asym str;  
A 1004.218 0.796 66.310 - - 15% ring def 
A 1002.458 2.248 6.000 - 1001 17% ring def, 
A 997.079 0.046 5.471 - - 40% CH twist 
A 994.543 0.021 0.168 995 - 51% CH twist 
A 986.865 0.114 0.032 - - 76%  CH twist  
A 985.731 0.323 0.587 - - 57% CH twist 
A 980.242 0.536 0.471 - - 60% CH twist 
A 958.160 0.062 0.698 - - 76 % CH twist 
A 942.116 0.302 1.048 - - 45 % CH twist 
A 938.770 0.479 1.134 938 938 62% CH twist 
A 917.797 7.344 3.801  - 
11% CH twist; 15% 





4.494 905 904 
20 % CC sym str; 
11%  ring breath; 
11% CH wag 
A 901.291 8.340 0.729 883 - 52% N-C ring breath 
A 865.908 4.803 5.796  - 
36 % N-C sym str; 
10% CH twist 
A 863.021 0.904 1.377  864 50 % CH twist 
A 859.903 0.608 1.362 860 - 54% CH twist 
A 853.208 0.467 0.049  - 49% CH twist 




















0.619  - 66% CH wag 






0.983  - 
10% Cl-C sym str; 
15% ring breath, 












6.303  681 
26 % ring breath; 




3.952 669 660 
13% ring breath; 
29% CH wag  
A 642.789 5.946 1.648  648 
19% CH twist; 15% 
ring breath 
A 638.744 9.153 3.490 633 634 
26% ring breath; 
10% CH wag  
A 627.640 0.451 2.712 - - 
49% ring breath, 
12% CH wag  
A 623.786 0.527 3.632 - - 64 % ring breath 
A 620.859 0.893 4.129 620 621 
25% N-C wag; 12% 
ring breath 
A 540.857 0.893 0.255 531 531 
22% CH twist; 11% 
CH wag 
A 516.816 3.067 0.575 - - 
34% CH wag; 11% 
CH twist 
A 505.983 1.096 0.558 495 498 
17% Cl-C wag; 11% 
CH twist 
A 465.239 3.399 0.137 466 - 
19% CH twist; 31% 
Cl-C wag  
A 438.359 5.473 6.772 434 447 
41% Cl-C sym str; 
17% ring breath 
A 421.038 0.061 0.068 - - 46% CH twist 
A 411.586 0.489 0.209 412  47% CH twist 
A 396.270 1.023 5.183 -  
45% -Cl-C sym 
bend; 11% C-C bend 
A 338.257 0.332 1.429 -  
12% C-C asym bend; 
33% N-C sym bend  
A 317.007 0.690 2.018 -  
10% C-C rock; 21% 
N-C wag 
A 304.150 1.054 0.474 -  
24% C-C asym str; 
29% Cl-C bend 
scissors 
A 294.938 0.448 3.045 -  
11% out of plane 




A 289.721 0.091 2.579 -  
11% C-C bend; 10% 
N-C bend  
A 263.293 0.306 3.124 -  
10% C-C bend; 10% 
N-C bend  
A 258.312 0.375 1.194 -  
19% C-C bend 
scissors; 10% -N-C 
bend  
A 250.517 1.014 3.895 -  
11% N-C bend 
scissors 
A 176.884 0.222 2.180 -  
24% C-C bend; 29% 
Cl-C wag  
A 153.152 0.125 1.665 -  
15% ring rock; 21% 
Cl-C twist 
A 119.855 0.257 5.364 -  
31% C-C out of 
plane bend; 14% N-C 
out of plane bend 
A 107.287 1.094 1.018 -  
10% N-C tors; 36% 
CC tors  
A 95.706 0.669 0.622 -  
25% C-C tors; 30% 
N-C tors 
A 81.099 0.987 1.955 -  
34% C-C tors; 18% 
N-C tors 
A 73.731 0.453 8.034 -  
36% CC tors; 15% 
NC tors  
A 63.533 0.099 3.878 -  
11% CCN rock; 10% 
CCC rock  
A 58.757 0.231 3.460 -  
27% N-C twist; 20% 
C-C twist 
A 52.406 0.388 6.308 -  
44% N-C twist; 10% 
C-C twist 
A 37.707 0.526 0.355 -  
25% C-C twist; 41% 









4.1.4 Frontier molecular orbitals 
The HOMO (Highest Occupied Molecular Orbital) and LUMO (Lowest Unoccupied 
Molecular Orbital) are collectively known as the FMO (Frontier Molecular Orbital). They are 
an important quantum chemical parameter which help in understanding the bonding and 
adsorption properties of a compound especially when it comes to the use of compounds as 
corrosion inhibitors. The energy of the HOMO relates to ability of a compound to bind to a 
metal surface. A high HOMO energy indicates a good electron donation ability while a small 
HOMO-LUMO gap encourages the donation between the molecular orbitals of the compound 
and the orbitals of the metal surface such that a high adsorption will be detected [103]. The 
FMO values for CTZ are -6.155 eV and -1.277 eV for the HOMO and LUMO respectively 
while the energy band gap is 4.878 eV. It is observed that the HOMO occurs in the imidazole 
ring and this is mainly due to the presence of the nitrogen atoms while the LUMO occurs on 
the benzene rings which is due to the pi-electrons (Fig. 7). The FMO results indicated that 
CTZ has a good potential as a corrosion inhibitor and this has been reported in its ability to 

























4.1.5 Molecular Electrostatic Potential  
The Molecular electrostatic potential (MEP) map indicates the charge distribution in a 
molecule which is useful in knowing the potential sites for nucleophilic and electrophilic 
attacks. The blue region is positive and indicates nucleophilic reactivity while the red and 
yellow regions are negative and denote electrophilic reactivity. The electronegative regions 
occurred on N12 of the imidazole ring (red) and the chlorine atom (light yellow) though the 
former is more electronegative while the blue region occurred on the hydrogen atoms of the 


























4.1.6 Molecular docking studies 
Recent studies [44], [45], [49], [105]–[107] suggest that secreted aspartic proteinases 
(SAPs),  particularly SAPs 1-10 are virulent proteins which play an important role in the 
infection  caused by C. albicans and hence should also be a drug target. These proteins are 
mostly found in the cell membrane [32] which implies they can easily interact with the host 
cells. Unfortunately, most of the crystal structure of the SAP proteins are not available in 
the protein database. For this study, the SAP2 protein was used with PDB ID: 1EAG [108]. 
Docking, which is the technique that predicts the best possible orientation known as a pose 
by which a ligand (drug) can interact a protein to form a steady complex [109]. This method 
is relatively new as it is one of the Computer Aided Drug Design (CADD) methods and it 
has also been used in the study of CTZ with CYP121 of another pathogen responsible for 
Tuberculosis, Mycobacterium tuberculosis [110]. MOLEMAN 2 was used to validate the 
target protein (SAP2) using Ramachandran plot (Fig. 9b). For a protein to be valid, it is 
recommended that the outlier percentage does not exceed 5% [111]. The outlier percentage 
of the target protein was detected to be 2.6% and hence was valid to be used for molecular 
docking analysis. The CLC drug discovery workbench program [96] was used for the 
molecular docking studies. The optimized structure of all the three conformers from 
Gaussian 09 were used as the ligand input file for the docking process while the complex 
A70450 present in the initial structure of the target protein was set as the reference ligand 
to establish the binding site (Fig. 9a) which gave the following binding parameters; 41.480,  
22.670 and  12.460 for the X,Y and Z axes respectively. All the water molecules and ligand 
present in the initial structure were all removed from the target protein before docking the 
ligands and the docking was done with a radius of 13 Å in the binding site. The total 
docking score is a sum of the Hydrogen Bond (HB), Steric Interaction (SI) and ligand 
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Conformation Penalty (LCP) score values. All the three possible conformers showed good 
binding scores since they all had negative values when bound to the target protein. The 
steric interaction score had the highest contribution to the final docking score. Though, 
there was no significant difference in their score values (Table 4). The Drug discovery 
studio program [97] was used to visualize the binding mode and molecular interactions of 
CTZ with the target protein. However, since they all had similar docking scores only the 
binding mode of conformer B which is the most stable was depicted (Fig. 10).  The 
molecular interactions of CTZ with the target protein includes two carbon-hydrogen bonds 
with SER 118 and ASP 120; Pi-alkyl interactions with ILE 30, ILE 119 and ILE 123; Pi-
pi T-shaped interaction with TYR 84 and Pi-anion with ASP 120.  













A 0.00 -42.14 1.70 -40.44 
B -2.00 -39.86 1.63 -40.23 




























DFT studies using potential energy scan gave rise to three possible conformations of 
clotrimazole in both gas and aqueous phases. Extensive vibrational analysis was done to 
assign the spectroscopic bands. The molecular electrostatic map indicated that the positive 
region around the benzene rings while the negative region occurred on the imidazole ring. 
The frontier molecular orbitals revealed that the HOMO occurred on the imidazole ring 
while the LUMO occurred on the benzene rings. Molecular docking showed that all the 
possible conformers had good binding affinities with the target protein (SAP2). The 
molecular interactions include hydrogen bonding and steric interactions with the amino 
residues TYR, ASP and ILE present in the binding site. This molecular interactions could 















4.2 Resorcinol  
4.2.1 Structure and vibrational properties 
All theoretical levels employed in this study have predicted consistently that AS is the most 
stable form which is around 0.2 and 0.7 kcal/mol more stable than A and S forms, 
respectively. The prediction on the rotational constants with respect to the x, y and z 
coordinates are also in excellent agreement with experimental values (Table 6). Whereas 
the B3LYP level predicted the existence of three rotamers strictly planar with no imaginary 
frequencies, free-of-symmetry-constrain more accurate MP2 and MP4 optimizations 
predicted the hydroxyl group to very slightly tilt from the plane of the molecule. Like 
phenol, resorcinol in its electronic ground state adopts a planar configuration as it keeps 
the oxygen lone pairs of electrons in a position encountering the least possible 
intramolecular repulsion. The rotational barrier around the C-O bond predicted from the 
MP2 and B3LYP levels was found to be 3.5 and 3.8 kcal/mol, respectively.  
To attain a better understanding of the nature of the intermolecular hydrogen 
bonding in the crystal phase of resorcinol and the bioactivity of the resorcinol molecule 
towards the target protein, we focused on the conformational properties arising particularly 
from the internal rotation by the two hydroxyl groups.  The derived PES scan (Fig. 14) in 
terms of both CC-OH dihedral angles (denoted as φ1 and φ2) revealed that in non-condensed 
phases resorcinol molecule interchanges from one form into another through the AS route, 
i.e., in the AS ↔ A ↔ AS or AS ↔ S ↔ AS interchange patterns. On the other hand, at 
least 7 kcal/mol is required for the A ↔ S ↔ A or S ↔ A ↔ S types of conformational 
interchange which is less likely to take place. The MP2/6-311++G(d,p) characterized the 
44 
 
three possible minimum forms to be more flat than that predicted by the B3LYP/6-
311++G(d,p) level of theory. This supported the assumption that the molecule in the solid 
lattice is capable of adopting an internal arrangement that maximizes the extent of the 
intermolecular hydrogen bonding, whose influence in turn can be clearly observed from its 
high melting point and low solubility. The structural parameters of the optimized unit cell 
of -resorcinol were in good agreement with those have been determined by the x-ray 
experiment [112] Furthermore, the unit cell (Fig. 11) adopts an overall near Cs symmetry, 
wherein some of the hydroxyl groups tend to deviate from planarity (Table 7) to facilitate 
O-HO intermolecular bonding. The difference between the calculated non-bonded HO 
distances (in the order of 1.9 Å) and that reported experimentally (1.7 Å [112]) implies the 
very strong packing forces facilitated by intermolecular hydrogen bonding in resorcinol.  
The comparison between the calculated B3LYP/6-311++G(d,p) and the 
experimental (gas [10] and solid [32]) bond lengths, bond angles and dihedral angles of the 
most stables forms of resorcinol (anti A and anti-syn AS), its dianion salt and the α-unit 
cell has been listed in Table 7. The bond lengths and most of the bond angles do not vary 
much between the two rotameric forms, nor deviate much from those reported for the solid 
phase.  The changes of the structural properties for the benzene ring in going from 
resorcinol to its dianion salt are quite interesting and some insights could be noticed by 
carefully comparing the obtained computational and spectroscopic data. The aromatic C-
C bonds in the dianion salt were predicted to be in average 0.05 Å longer than compared 
to the parent molecule. The transformation to the dianion form makes the electron pairs on 
oxygen tend to delocalize more, resulting in the development of a trace -character across 
the C-O bonds, which in turn distort the uniformity of the electron density of the benzene 
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ring. This can be viewed from the variation in the calculated C-C bond distances and CCC 
angles as well as from the lesser sp2 character depicted by the deviation of the hydrogen 
atoms from the planar configuration. The observed shifts in the infrared and Raman 
spectral bands associated with the ring and C-O modes (Tables 8-10) support the 
calculation findings and are clarified further in the next section. The 1H NMR data support 
the structural influence of abstracting the hydroxyl hydrogens from the resorcinol ring.   
The resonance peak at  4.72 ppm due to hydrogen of hydroxyl function in resorcinol 
disappeared in both resorcinol-OD and dianion. In addition, the aromatic signals in dianion 
exhibited slight upfield shift compared to parent compound. This was indicative of electron 
shielding effect due to increased flux of electron density from oxygen lone pairs into the 
aromatic ring.  
The assignments of local vibrational modes of resorcinol, its deuterated isotopomer 
and dianion salt derivatives in the solid phase were given in Tables 3-5. While a number 
of reports had proposed the vibrational assignments of resorcinol in the condensed and gas 
phases [6, 11,13,15,24,25,26,29] , the assignments presented here were made on a 
comparative basis with resorcinol derivatives. An overview of the previous infrared and 
Raman vibrational assignment reports [76]  performed on resorcinol showed that most of 
the features of the solid-phase and gas-phase spectra are of high similarities. In the current 
study, the assignments of vibrational modes associated with the hydroxyl groups were 
affirmed by monitoring the isotopic shifts in the spectra the -OD isotopomer and the 
disappearance of such modes in the dianion salt spectra, supported by theoretical 
frequencies. To insure more reliable assignments and account for possible intermolecular 
interactions, the infrared and Raman wavenumbers of -resorcinol and its –OD derivative 
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were compared with the calculated ones for the optimized unit cell structure (Tables 8 and 
9). 
The 36 vibrational modes in resorcinol and its -OD derivative, which adopt C2v 
symmetry for the A form, span the irreducible representations: 13 A1 + 4 A2 + 12 B1 + 7 B2, 
while in the case of the dianion salt, due the absence of the two alcoholic hydrogens, there 
are 30 vibrational modes that span the irreducible representations: 11 A1 + 3 A2 + 10 B1 + 
6 B2. According to the symmetry selection rules A2 modes are expected to be only Raman 
active. However, since in the solid phase resorcinol was reported [33] and calculated at the 
MP2 and MP4 levels to be slightly non-planar, some of the A2-symmetry modes, namely 
ν14 and ν15, absorb very weekly in the infrared spectra. Such modes, however, could be 
located for the dianion salt only in the Raman spectrum due to its strictly planar 
configuration. Calculated frequencies for single molecules agree in most of the cases with 
those experimentally observed in the solid phase vibrational spectra. However, the values 
of some of the computed frequencies were noticed to be smaller than the corresponding 
observed ones. These vibrations belong mainly to A2 and B1 symmetries which describe 
out-of-plane modes. The higher experimental values of the solid phase facilitated by strong 
packing forces are somehow due to hindrance of out-of-plane vibrations and hence requires 
slightly greater vibrational energies. This motivated us to recalculate the vibrational 
frequencies for -resorcinol (rotamer A) but in the environment of the unit cell (Fig. 11) 
rather than a single molecule. The deviated frequencies in the case of the isolated molecular 
system were improved and showed better agreement with experimental values of the solid 
phase especially for the bending modes below 1000 cm-1 (Tables 8 and 9). For instance, 
the O-H wagging (O-D wagging for the OD isotopomer) mode, ν16 , were calculated to be 
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in the range of 337-350 cm-1 (250-252 cm-1) in the case of unit cell and 304 cm-1 (219 cm-
1) for isolated molecules, compared to the observed 358 cm-1 (249 cm-1) values.  
The observed broad infrared band nearly at 3180 cm-1 which is associated with the 
stretching modes of the intermolecular hydrogen-bonded –OH group was shifted upon 
deuteration down to 2387 cm-1 with the band pattern and intensity being retained indicating 
the existence of appreciable hydrogen bonding in the case of the isotopomer sample. The 
asymmetric and symmetric O-D stretching vibrations were resolved in the Raman spectrum 
as by the weak lines observed at 2452 cm-1 and 3033 cm-1, respectively. The in-phase in-
plane O-H wagging mode observed as a medium intensity infrared band at 1166 cm-1 (DFT 
is 1188 cm-1) in the resorcinol spectrum was shifted to 951 cm-1 (DFT is 929 cm-1) as a 
strong infrared band in the spectrum of the isotopomer derivative. The isotopic shifts 
associated with the hydroxyl groups in the solid phase and defined as νResorcinol/ νResorcinol-
OD were found to be greater for the stretching vibrations (1.33) compared to the bending 
ones (1.23) which could be attributed to the more significant involvement of the stretching 
modes in the hydrogen bonding compared to the corresponding bending ones. 
Moreover, some vibrational frequency shifts were noticed because of the 
abstraction of the acidic protons from the resorcinol molecule (Figs. 12 and 13). The C-O 
in-phase (ν7 at 1281 cm
-1 with 67% PED) and out-of-phase (ν27 at 960 cm
-1 with 33% PED) 
were shifted to higher frequencies (1404 and 1236 cm-1, respectively) and become less 
coupled with other modes (75% calculated PED vales). This is due, as indicated earlier, to 
the more pronounced -electron character associated with the C-O bonds and hence shorter 
bond lengths in the case of the dianion salt. This is accompanied with non-uniformity of 
the electron cloud across the benzene ring as supported by noticeable downward shifts of 
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the observed wavenumbers for the C-C stretching as going from resorcinol to its dianion 
derivative. For instance, the ring breathing mode observed as the strongest Raman line at 
998 cm-1 for resorcinol has shifted to 977 cm-1 in the Raman spectrum of the dianion salt 
(Fig. 13). This is also true for other ring stretching modes such as ν5 , ν6 , ν20 and ν21 . 
Optimized DFT structures (Table 7) predicted an average increase in the C-C bond distance 
from 1.40 to 1.45 Å, and a decrease in the C-O bond distance from 1.356 to 1.296 Å, in 
going from resorcinol to its dianion salt. In addition, the C-H bonds was shown to be 
slightly less stiff in the case of the dianion salt where they absorbed as low as 2978 cm-1 in 
the infrared spectrum with excellent agreement with the theoretical values (Table 10). 
Table 5.  Calculated relative stabilities (kcal/mol) for the anti-syn (AS), anti (A) and syn 
(S) conformations of resorcinol1. 
 




























1.The calculated structures at the MP2 and MP4 levels are for C1 symmetry of resorcinol. 




Table 6. Rotational Constants calculated at different levels of theory for the anti-syn 
(AS), anti (A) and syn (S) conformations of resorcinol in GHz compared with 
experimental values.  
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X Y Z X Y Z 
Experimental AS 3.758 1.831 1.231 - - - 
 A 3.755 1.834 1.233 - - - 
 S 3.766 1.824 1.229 - - - 
B3LYP AS 3.766 1.830 1.232 3.737 1.802 1.225 
A 3.762 1.834 1.233 3.758 1.833 1.232 
S 3.776 1.823 1.230 3.772 1.822 1.229 
MP2 AS 3.748 1.824 1.227 3.742 1.822 1.225 
A 3.738 1.829 1.228 3.719 1.812 1.223 
S 3.766 1.815 1.225 3.759 1.812 1.223 
MP4SDQ AS 3.751 1.826 1.228 3.745 1.824 1.227 
A 3.746 1.829 1.229 3.740 1.829 1.228 
S 3.760 1.819 1.226 3.755 1.817 1.225 







Table 7.  Structural parameters of the Resorcinols A, AS and the α-unit cell from both observed and calculated at the B3LYP/6-311++G 
(d,p) levels of theory. All bond lengths are in Å and angles in degrees 
  A AS α-Unit Cell 
Salt 
Bond 
Lengths Obs. a Calc. Obs. a Calc. Obs.b Calc.c 
C1 - C2 1.394 1.396 1.388 1.4 1.396 1.393 1.436 
C2 - C3 1.396 1.401 1.388 1.397 1.399 1.398 1.451 
C3 - C4 1.407 1.397 1.408 1.402 1.397 1.392 1.402 
C4 - C5 1.407 b 1.397 - 1.393 1.393 1.392 1.402 
C5 - C6 1.396 b 1.401 - 1.402 1.400 1.398 1.451 
C6 - C1 1.394 b 1.396 - 1.395 1.395 1.393 1.436 
C1 - H11 1.086 1.085 1.091 1.087 1.088 1.083 1.094 
C2 - O7 1.357 1.369 1.371 1.37 1.378 1.371 1.296 
C3 - H9 1.086 1.087 1.091 1.087 1.089 1.084 1.092 
C4 - H12 1.086 1.087 1.091 1.087 1.087 1.084 1.099 
C5 - H10 1.086 1.087 1.091 1.085 1.087 1.085 1.093 
C6 - O8 1.357 1.369 1.371 1.369 1.374 1.371 1.296 
O7 - H13 0.955 0.96 0.959 0.96 1.003 0.966 - 
O8 - H14 0.955 0.96 0.959 0.96 1.005 0.966 - 
Bond Angles 
C1-C2-C3 120.68 120.92 120.68 120.8 121 120.32 115.2 
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C2-C3-C4 119.41 118.93 119.41 118.9 118.5 119.51 120.2 
C3-C4-C5 120.14 121.12 120.14 121.4 121.6 121.12 123 
C4-C5-C6 119.41c 118.91 - 118.8 118.8 119.03 120.2 
C5-C6-C1 120.68c 120.92 - 120.9 120.7 120.32 115.2 
C6-C1-C2 119.68 119.21 - 119.3 119.3 119.12 125.7 
C3-C2-O7 119.6 122.33 119.6 122.8 122.4 121.83 121.5 
C5-C6-O8 122.18 122.33 119.6 117.1 122 121.83 121.5 
C2-C1-H11 120.16 120.42 120.16 119.2 120.2 120.42 117 
C6-C1-H11 120.29 120.42 - 121.5 120.5 120.42 117 
C2-O7-H13 108.55 108.63 - 108.5 111.8 109.92 - 
C6-O8-H14 108.55 c 108.63 - 108.8 111.8 109.91 - 
C2-C3-H9 120.29 120.42 - 120.4 120.9 120.42 118.2 
C6-C5-H10 120.29 c 120.42 - 119.4 120.8 120.42 118.2 
Dihedral Angles 
C3-C2-O7-H13 - 0 - 180 6.9 4.75 - 
C5-C6-O8-H14 - 0 - 0 9.7 5.21 - 
C5-C6-C1-H11 - -180 - 180 180 180 180 
C2-C3-C4-H12 - 180 - 180 180 180 180 
C1-C2-C3-H9 - 180 - 180 180 180 180 











Figure 11. Structure of α-resorcinol unit cell as optimized at the B3LYP/6-311g(d,p) 











Figure 12. Mid-infrared spectra of (a) α-resorcinol (solid), (b) α-resorcinol unit-cell (calculated), (c) α-resorcinol-OD isotopomer 





















Figure 13. Raman spectra of (a) α-resorcinol (solid), (b) α-resorcinol unit-cell (calculated), (c) α-resorcinol-OD isotopomer (solid), (d) 









                                                              
 
Figure 14. (a) 3D potential energy scan and (b) contour plot describing the relative 







































 ν2   C-H str.(100%) 
3095 
3090-3093 
  3071 ms 
 ν3   C-H str.(93%) 
3074 
3073-3082 
  3056 ms 
 ν4   C-H str. ip (93%) 
3047 
3044-3056 
  3043 w 


























m 1167 w 





w 1084 ms 





vw 998 vvs 
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m 740 s 



































  358 w 
 ν17  Ring def. (76%) 
227 
231-237 
  244 s 
B1 






 ν19  C-H str. op 
(100%) 3052 
3056-3065 
  3116 w 





























 ν24  O-H wag op 
(31%) 1207 
1231-1260 
1207  ~1230 w,br 
 ν25  C-H wag(68%) 
1165 
1165-1170 
1179  1162 w 
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s 1143 vw 





ms 957 w 




 530 m 




 499 vw 


















ms 766 w 
 ν33  Ring def. (59%) 
629 
676-682 611 681 
m 
678 w 





m 459 w 





   
 ν36  Ring def. (95%) 
216 
226-231 
  193 w 
* Given in terms of a C2v-symmetry structure. 
** Abbreviations: ip = in-phase, op = out-of-phase,  























A1 ν1   O-D str.(100%) 2696 2609-2693 2387 vvs 2452 w,br 
 ν2   C1-H str.(100%) 
3095 
3090-3093 3068 m 3066 ms 
 ν3   C4-H str.(93%) 
3074 
3073-3082  3050 w 
 ν4   C-H str. ip (93%) 
3047 
3049-3056  3034 m 
 ν5   Ring str.(65%) 
1604 
1595-1612 1597 vs 1597 ms 
 ν6   Ring str.(65%) 
1481 
1480-1481 1465 s 1468 vw 
 ν7   C-O str. ip (40%) 
1303 
1299-1307  1301 ms 
 ν8   O-D wag ip 
(83%) 914 
921-929   951 s ~953 
vw,br 
 ν9   C-H wag ip 
(44%) 1095 
1091-1097 1086 w,br 1087 ms 
 ν10  Ring breath 
(45%) 995 
994-998    999 vvs 
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 ν11  Ring bend 
(43%) 733 
731-737   730 m   734 vs 
 ν12  Ring bend 
(62%) 527 
526-532   529 m   532 m 
 ν13  CCO def. ip 
(77%) 312 
316-335    395 w 
A2 
ν14  C-H wag op 
(76%) 806 
827-833 
  793 vvw 
 
 ν15  Ring def. (76%) 
608 
611-622    616 m 
 ν16  O-D wag op 
(95%) 219 
250-252,422,442    341 w 
 ν17  Ring def. (76%)  
232 
206-228    180 w 
B1 




 ν19  C-H str. op 
(100%) 3052 
3056-3065  3080 w 
 ν20  Ring str. (66%) 
1632 
1625-1634  1612 sh 
 ν21  Ring str. (100%) 
1494 
1491-1499 1484 s  
 ν22  Ring str.(56%) 
1334 
1332-1334 1339 vw 1330 vw 
 ν23  C-H wag ip 
(64%) 1296 
1288-1297 1286 s 1285 vw 
 ν24  O-D wag op 
(36%) 920 
942-967   
 ν25  C4-H wag (31%) 
1173 
1173-1177 1169 sh 1167 vw 
 ν26  C1-H wag (68%) 
1150 
1146-1152 1147 s 1150 w 
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 ν27  C-O str. op (33%) 
971 
967-988   995 ms   989 m 
 ν28  Ring bend 
(74%) 517 
515-521    521 m 
 ν29  CCO def. op 
(84%) 443 
461-483    490 vw 




 ν31  C1-H wag (68%) 
834 
844-862   841ms   842 w 
 ν32  C-H wag ip 
(83%) 723 
746-752   767 ms   766 w 
 ν33  Ring def. (59%) 
629 
676-680   678 ms   681 w 
 ν34  Ring def. (80%) 
449 
457-459   455 m   460 w 
 ν35  O-D wag ip 
(95%) 189 
263-266,420,445   





























A1 ν1   O-H str.  -   
 ν2   C-H str.(90%) 2980  3012 m 
 ν3   C-H str.(93%) 2902 3041 vm 3042 w 
 ν4   C-H str. ip (84%) 2992 2978 vm  
 ν5   Ring str.(31%) 1482 1461 
ms,br 
1475 vm 
 ν6   Ring str.(34%) 1306   
 ν7   C-O str. ip (74%) 1385 1404 w 1407 w 
 ν8   C-H wag ip (47%) 1043 1063 w 1067 s 
 ν 9  Ring breath 
(66%) 
939 
  965 m   977 vs 
 ν11  Ring bend (56%) 738   771 w   769 w,sh 
 ν12  Ring bend (69%) 529   510 vw  
 ν13  CCO def. ip 
(68%) 
364    407 w 
A2 ν14  C-H wag ip (55%) 577    
 ν15  Ring def. (955) 722    757 vvs 
 ν16  Ring def. (89%) 191    185 
B1 ν17  C-H str. op 
(100%) 
2982 
 3031 w 
 ν20  Ring str. (67%) 1540 1551 ms  1556 m 
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 ν21  Ring str.(33%) 1442 1448 ms  
 ν22  Ring str.(49%) 1281 1318 m 1332 m  
 ν23  C-H wag ip (76%) 1043   




 ν25  C4-H wag  (43%) 929   927 w,br  
 ν26  C1-H wag (42%) 1184  1142 m 1148 m 
 ν27  C-O str. op (75%) 1241 1236 m 1237 m 
 ν28  Ring bend (88%) 496   467 br,w   463 vw 
 ν29  CCO def. op 
(75%) 
521   510 vw   515 w 
B2 ν30  C-H wag (58%) 
791   832 m   770 w 
 ν31  C-H wag (25%) 730   713 m   710 vm 
 ν32  C-H wag ip (74%) 635   618 br,m   627 brw 
 ν33  Ring def. (94%) 576   546 vm   549 m 
 ν34  Ring def. (76%) 290    251 m 
 ν36  Ring def. (79%) 133    154 ms 
* Same normal mode descriptions as in resorcinol and its isotopomer are used for easier comparison. 








4.2.2 Molecular docking analysis 
During the past decades resorcinol exhibited a number of medical applications, 
especially as it is used as a starting material to prodcue derivatives of Active 
Pharmaceutical Ingredients (API) for treating Alzheimer’s disease, sickle cell anemia and 
alcoholism [22]. However, resorcinol itself has been also used as a topical agent in treating 
dermatological diseases such as eczema, acne and Hidradenitis Suppurativa (HS). 
Molecular docking is a useful tool used in structure-based drug design (SBDD) to predict 
binding affinities of an API with specific protein targets [30] that play a role in the 
pathology of a disease. Resorcinol possess keratolytic properties and hence is known to 
target the follicular keratin plug which is the initiation stage of several HS lesions [29]. 
Therefore, a molecular docking analysis is useful to provide insights on the modes of action 
of resorcinol in treating HS. The structure of  the target protein, keratin-7, was obtained 
from the protein database bank with PDB ID-4XIF [113], and Ramachandran plot was 
carried out to validate its structure where target protein should maintain a Ramachandran 
outlier less than  5% [95].  The Ramachandran plot gave an outlier value of  2.769% which 
indicated a good quality protein which  can be used to accomplish conclusive molecular 
docking scenarios.   
The optimized structures of the three resorcinol rotamers (Scheme 1) were trailed 
for docking with keratin-7 (Fig. 15). The binding affinities in terms of score values of the 
generated pose structures of resorcinol after binding with the protein are listed in Table 11. 
The three conformers of resorcinol showed similar binding affinities towards keratin-7 
indicating that the stable mode of action of resorcinol with the target protein is irrelevant 
of the rotameric form it undergoes. Moreover, the steric interactions were expected to play 
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the major role in the docking process compared to hydrogen bonding. Due to the small size 
of the resorcinol molecule, keratin-7 seems to be capable of availing sterically favored 
regions to accommodate stable protein-ligand binding. Steric interaction is made up of non-
polar, polar to non-polar, repulsive interactions, etc. that other than hydrogen bonding 
interaction [96].  
Docking analysis, moreover, showed that while hydrogen bonding is not the most 
significant factor compared to steric interaction as discussed above, yet it shows an 
appreciable contribution to the stable protein-ligand long-distance binding. For example, 
in the case of rotamer AS, the computed favorable possibilities included three different 
hydrogen bonding interactions represented in Fig. 16 and were carefully tracked. Due to 
their high electronegativity, the two oxygen atoms of resorcinol exhibited a significant role 
in the biological activity of the ligand towards keratin-7. The molecule of resorcinol acts 
as both a hydrogen bond donor and acceptor towards ASN 557 giving rise to a stable 
conventional hydrogen protein-ligand bonding. Non-conventional O···HC interaction 
between resorcinol and THR 809 with a calculated distance of 2.6 Å was also predicted 
[114]. On the other hand, a hydrophobic interaction of pi-alkyl type with LYS 898 is well-
maintained within an approximity of 4.5 Å. These four interactions account for the binding 
affinity for AS and, with the remarkable facilitation of the steric factor, are responsible for 
the keratolytic properties of resorcinol with keratin. Other two rotamers also showed 





Table 11. Binding affinities of different conformers of resorcinol with Keratin (PDB ID: 
4XIF) 
Rotamer 










A -9.53 -27.75 0.00 -37.28 
B -9.69 -26.99 0.00 -36.68 
C -7.56 -27.64 0.00 -35.20 
D -10.00 -27.56 0.00 -37.56 
A 
A -9.38 -27.45 0.00 -36.83 
B -9.60 -27.04 0.00 -36.63 
C -9.61 -26.96 0.00 -36.57 
D -10.00 -27.27 0.00 -37.27 
S 
A -9.50 -27.85 0.00 -37.34 
B -9.40 -27.13 0.00 -36.53 
C -9.99 -26.33 0.00 -36.32 


























Figure 15. The tertiary structure of keratin-7 (PDB ID -4XIF). The binding site is 


















Figure 16. (a) The binding modes, and (b) molecular interactions of AS rotamer with the 
amino residues of keratin-7 (PDB ID: 4XIF). Interactions labelled as green, red and 
purple refer to hydrogen-bonding, carbon-hydrogen, and -alkyl types of interaction, 










The B3LYP/6-311++G(d,p) computational method was utilized to optimize the unit cell of 
the crystal structure of -resorcinol and to calculate the associated harmonic frequencies 
helped in understanding some spectroscopic differences in the infrared and Raman spectra 
between the solid and the gas phases. The potential energy distribution of the normal 
vibrational modes was done using the VEDA program. The AS rotamer is the most stable and 
also was the best pose in which the resorcinol molecule bound to the target protein keratin-
7(PDB-4XIF) in the molecular docking analysis which gave an insight to the keratolytic 
property of resorcinol in HS lesions. 
 
 
4.3 Molecular Docking of other Bioactive compounds 
4.3.1 Molecular Docking of MNPE 
The validation of the structure of the target protein is an essential step in the drug discovery 
process [115]. The crystal structure of a human GABA receptor  (PDB ID: 4COF) shown 
in Fig. 10a was done at a resolution of 2.97 Å and was used as the target protein [116]. The 
target protein contains 5 possible binding sites, namely chains A, B, C, D and E. Each chain 
is consisted of about five α-helices which are spiral in shape and about 8 β-pleated sheets. 
Ramachandran plot (Fig. 17b) checked a total number of 1574 residues out of the 1665 
amino residues present in the target protein, which is tantamount to about 95% of the total 
residues. The total number of core regions and outliers are 1546 and 28 respectively, which 
gave a rise to a percentage outlier of 1.8 %. The Ramachandran plot uses percentage outlier 
to ascertain the validity of a protein structure. The recommended range for the percentage 
outlier for  a valid protein structure is between 0 to 5 % [95]. Hence, the target protein 
(PDB ID: 4COF) used for the molecular docking was valid. The five binding sites of the 
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benzamidine molecule, A, B, C, D and E, complexed with the crystal structure of the target 
protein (PDB ID: 4COF) were used for docking analysis. Benzamidine is an agonist for 
the human GABA receptor [116] and hence its binding site was used as a reference for the 
molecular docking analysis. Table 12 lists the molecular docking results of (4-(3-methoxy-
4-nitrophenyl)piperazin-1-yl)ethanone (MNPE) and human GABA receptor. Binding site 
C which is the reference site for BEN C in the original crystal structure had the highest 
total docking score value which implies that MNPE exhibits the best binding affinity 
towards the target protein within this binding site. The total score value is the sum of the 
Hydrogen Bond (HB) score, the Steric Interaction (SI) score and the ligand penalty 
conformation.  It was also predicted that the ligand in binding cite C has the lowest ligand 
conformation penalty value (7.910) and the most negative steric interaction score (-59.781) 
among the different binding sites. Four types of favorable interactions (Fig. 18) between 
MNPE and the target protein could be established.  The favorable interactions between 
MNPE and the target protein included conventional hydrogen bonding with amino acids 
THR 202 and GLN 64, π-π stacking and π-alkyl interactions with PHE 200, TYR 62 and 
TYR 205, and carbon hydrogen bond with ASP 43 and TYR 157 (Fig. 18). The molecular 
docking analysis involved the generation of five low energy conformational scenarios 
known as poses. Unlike regular conformations, a pose structure is dependent on the target 
protein. Each pose was screened against the target protein in each of the five binding sites, 
A thru E. The binding mode conformation of MNPE in a binding site C have shown the 
best binding affinity (Fig. 18). During molecular docking analysis, the molecule orientated 
itself such that there exists an intramolecular hydrogen bonding between one of the 
hydrogens of the piperazine ring and the oxygen of the carbonyl group. The comparison 
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between the most stable conformer (B4) and the best binding pose from the molecular 
docking analysis is depicted in Fig. 19. It was evident that the docked pose and most stable 
conformer of MNPE were similar with respect to the position of the various functional 
groups except that the structure of the binding pose is contracted due to the presence of 
intramolecular hydrogen bonding along with its orientation of the flexible bonds in the 
molecule. The difference in the structure of the binding pose arises because in molecular 
docking the molecule would orientate itself such that it best-fit into the binding pocket of 
the target protein to ensure adequate binding. 
 




















A -6.000 -53.167 6.611 -52.556 
B -5.513 -52.730 6.671 -51.572 
C -6.596 -59.781 7.910 -58.468 
D -8.628 -51.792 6.624 -53.795 











Figure 17. (A) The crystal structure of a human GABA receptor (PDB ID: 4COF). (B) 


















Figure 18. (A) Docked conformation of the title compound in binding site C of GABA 
(PDB ID: 4COF). (B) The molecular interactions of MNPE and amino acids in binding 



















Figure 19. (A) Docked conformation of the title compound in binding site C showing the 
presence of intra-hydrogen bond (shown as yellow color). (B) The most stable 











 4.3.2 Molecular Docking of Gold Complexes 
The inhibition of thyroxine (TrxR) is important as a chemotherapeutic treatment, especially 
with the use of gold and platinum complexes especially the former which has been noted 
to be responsible in enzyme activity inhibition [117]. However, selenium has also proved 
to be useful in cancer treatment[118], [119].  Hence, the choice of docking the synthesized 
gold(1) complexes which all contain selenium with the target protein,  thioredoxin 
reductase (PDB ID: 3EAN) [120]. The protein was validated using the Ramachandran plot 
with the Moleman 2 [95] to check for the percentage outlier. For a valid protein, the 
percentage outlier should be between the range of 0 to 5 % [95]. The target protein proved 












Table 13. The docking results of gold(I) complexes (1-5) with human thioredoxin reductase-thioredoxin 
Compound 
Molecular 










1 735.6 2 4 7.05 8 2 -25.75 6.638 
2 763.7 1 4 6.87 9 2 -30.20 6.514 
3 777.7 1 4 8.41 10 2 -33.87 6.413 
4 763.7 1 4 7.67 8 2 -34.45 2.135 






       The CLC drug discovery workbench [63] program was used to dock the gold complexes to 
the TrxR (PDB ID: 3EAN). However, the initial ligands were extracted from the target 
protein before being docked with the gold complexes.  The active site in TrxR has been 
known to include Sec 498  (selenocysteine) which would lead to the formation of the gold-
selenolate specie [121] . Hence this was used as the binding site.    The complexes were all 
minimized using Spartan 16 program [122] before being docked in the binding site.  The 
Discovery studio program [97] was used to observed the binding mode and interactions 
present in the binding pocket of the docked results. All other amino acid interactions 
present in the binding mode were discarded except for Sec 498. The bond distance between 
the gold atom present in each complex and the Selenium atom in the Selenocysteine amino 
acid (Sec 498) was observed using the GaussView program [92].  Complex 4 had the 
shortest distance of 2.13 Å (Fig. 4) between the gold and selenium which implied that it 
had the best potential to form the gold-selenolate specie. This bond distance is in fact 
shorter than what was observed between Auranofin and selenocysteine [123]  which is 
5.897Å.  All the complex showed negative docking scores except complex 5 which implied 
that there was no binding affinity between the complex and the target protein (TrxR) since 
the more negative a docking score, the stronger the binding affinity. Moreover, the docking 
scores correlated with the bond distances between the gold and selenium atoms such that 
complex 4 which had the shortest bond distance also had the highest docking score and 
same applied to complex 5 (Table 13). 
All the complexes violated the Lipinski’s rule of five, by having a molecular mass and 
calculated logP (clogP) greater than 500 and 5 respectively. However, this does not deter 
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them from being used as potential anticancer therapeutics since they can all be optimized 










4.3.3 Molecular Docking of Ketoconazole 
The docking analysis of ketoconazole (KCZ)  with the crystal structure of an androgen 
receptor, PDB ID: 2AX6 [126]  was done using CLC drug discovery workbench 3.0 [96]. 
Ketoconazole is the first non-steroidal compound to bind competitively to a sex steroid 
globulin. Amongst other antifungal imidazole derivatives such as clotrimazole and 
fluconazole, ketoconazole is the only one which interacts with the androgen receptor [55]. 
It acts as an antagonist thereby making it useful in the treatment of androgen-dependent 
prostate cancer [126]. However, the mode of action of ketoconazole has not really been 
understood. Molecular docking is an in-silico method that is used in understanding the 
interactions between ligand in this case, ketoconazole and a target protein (androgen 
receptor). The validity of the target protein using Ramachandran plot gave an outlier of 
0.9%, which falls within the recommended range of 0-5% for a good quality protein [95]. 
The water molecules were removed before binding the ligand to the receptor and the initial 
ligand in the crystal structure of the target protein was used as the reference binding site 
within a radius of 13 Å. The number of iterations was set to 100 to get the best binding 
mode. After docking the ketoconazole to the androgen receptor, the ligand was optimized 
to give a docking score of -57.55 which implied a strong binding between the ligand and 
the receptor since the higher the negative value of a docking score the stronger the binding. 
The interactions between the ligand and the receptor showed many favorable interactions 
such as pi-alkyl, pi-cation, hydrogen bond and halogen bond with the amino acids found 
in the binding site and only two unfavorable interactions with MET 745 and GLN 711 (Fig. 
21). The binding mode and molecular interactions between ketoconazole, and the androgen 











Figure 21. (A) Docked conformation of ketoconazole in the active site of the androgen 









4.3.4 Molecular Docking of Methimazole 
Methimazole (MTZ) is one of the popular anti-thyroid drugs alongside propyl thiouracil. 
It acts by inhibiting the  enzyme thyroid peroxidase [15] which is responsible for the 
synthesis of thyroid hormone. Molecular docking helps in understanding the mode of 
action of methimazole on thyroid peroxidase. The structure of thyroid peroxidase was got 
from the protein database with PDB ID-1VGE [127]. Ramachandran plot which is a simple 
and popular way of validating protein structures [128] was used to confirm if the target 
protein was of good quality before docking it with the ligand (MTZ) using  Moleman2 
[95]. The percentage Ramachandran outlier for the enzyme thyroid peroxidase is 4.27%. 
This falls within the accepted range from a good quality protein, which is between  0-5% 
[95].  The AutoDock Vina [129] tool was used for the docking analysis. The ligand was 
first minimized before being docked with the target protein. The grid was maximized with 
a binding center of -22.3540, 26.5288 and 63.0403 for X, Y and Z axes respectively via 
the PyRx software [130]. The grid covered the whole target protein to ensure that all 
possible binding sites were considered to get the best binding mode. MTZ had a score value 
of -4.5 kcalmol-1 which showed good binding affinity with the target protein since negative 
values implies presence of binding affinity while positive values means no binding exist 
between the ligand and the protein. The Discovery studio visualizer [97] was used to view  
the possible interactions between MTZ and the target protein,  thyroid peroxidase as shown 
in Fig. 21. The CLC Drug Discovery workbench [96] was used to view the protein-ligand 
complex between MZM and the target protein. There were three types of favorable bonds 
present in the protein-ligand interaction of MTZ with thyroid peroxidase. The favorable 
bonds include the conventional hydrogen bonding to ASP167 and GLU165; a pi-sulfur 










Figure 22. (A) Docked conformation of MZM in thyroid peroxidase (PDB ID: 1VGE). 










The molecular docking analysis of MNPE showed that binding site C had the best binding 
affinity towards the human GABAA receptor. For the novel anti cancer seleno-complexes 
The molecular docking studies indicated that complex 4 had the highest binding affinity 
(−34.45) and showed the molecular interactions such as, van der Waals, pi-cation and alkyl 
with the amino group present in the target protein. Complex 4 also had the shortest bond 
distance between gold atom and Sec 498 of TrxR (2.13 Å), while complex 5 has the highest 
(7.68 Å). The molecular docking results of the complexes with human thioredoxin 
reductase enzyme would be helpful to explore their mechanism of action. The molecular 
interactions between Ketoconazole and the androgen receptor showed many favorable 
interactions such as pi-alkyl, pi-cation, hydrogen bond and halogen bond with the amino 
acids found in the binding site and only two unfavorable interactions with MET 745 and 
GLN 711 while the molecular docking studies of Methimazole with thyroid peroxidase 
revealed three types of favorable bonds including, the conventional hydrogen bon to 












[1] H. Song and H.-S. Shin, “The Antifungal Drug Clotrimazole,” Acta Crystallogr. 
Sect. C Cryst. Struct. Commun., vol. 54, no. 11, pp. 1675–1677, 1998. 
[2] I. Kurokawa, F. W. Danby, Q. Ju, X. Wang, L. F. Xiang, L. Xia, W. Chen, I. 
Nagy, M. Picardo, D. H. Suh, R. Ganceviciene, S. Schagen, F. Tsatsou, and C. C. 
Zouboulis, “New developments in our understanding of acne pathogenesis and 
treatment,” Exp. Dermatol., vol. 18, no. 10, pp. 821–832, 2009. 
[3] S. Bhambri, J. Q. Del Rosso, and A. Bhambri, “Pathogenesis of acne vulgaris: 
recent advances.,” J. Drugs Dermatol., vol. 8, no. 7, pp. 615–8, 2009. 
[4] I. M. Kapetanovic, “Computer-aided drug discovery and development (CADDD): 
In silico-chemico-biological approach,” Chem. Biol. Interact., vol. 171, no. 2, pp. 
165–176, Jan. 2008. 
[5] K. Mayura and B. Amol, “Role of Computational Chemistry in Drug Design,” vol. 
5, no. 1, pp. 55–67, 2015. 
[6] J. DiMasi, H. Grabowski, and R. Hansen, “Innovation in the pharmaceutical 
industry: new estimates of R&D costs. Journal of Health Economics,” J. Health 
Econ., vol. 47, pp. 20–33, 2016. 
[7] G. J. Sharman, “Conformation and Stereochemical Analysis of Drug Molecules,” 
eMagRes, vol. 4, pp. 105–116, 2015. 
[8] A. Paudel, D. Raijada, and J. Rantanen, “Raman spectroscopy in pharmaceutical 
product design,” Adv. Drug Deliv. Rev., vol. 89, pp. 3–20, 2015. 
[9] W. J. Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, 
Chang Z and K. C. W. J. Wishart DS  Guo AC, Shrivastava S, Hassanali M, 
Stothard P, Chang Z, “DrugBank: a comprehensive resource for in silico drug 
discovery and exploration,” Nucleic Acids Res., vol. 84, no. 24, p. 35, 2006. 
[10] K. Iwata, H. Yamaguchi, and T. Hiratani, “Mode of Action of Clotrimazole,” 
85 
 
Sabouraudia, pp. 158–166, 1973. 
[11] W. L. J. Chaffin, J. L. Lopez-Ribot, M. Casanova, D. Gozalbo, and J. P. Martinez, 
“Cell Wall and Secreted Proteins of Candida albicans : Identification , Function , 
and Expression,” Microbiol. Mol. Biol. Rev., vol. 62, no. 1, pp. 130–180, 1998. 
[12] R. A. Cihlar, R. L., Calderone, Methods in Molecular Biology, vol.499 - Candida 
Albicans. 2009. 
[13] G. C. Sauer, “The Fungus among Us The causative agent of the Candidiasis 
disease is a fungus,” Man. Ski. Dis. 6th Ed., pp. 1–5, 1991. 
[14] “Vaginal yeast infection,” National Institute of Allergy and Infectious Diseases, 
2015. [Online]. Available: 
http://www.niaid.nih.gov/topics/vaginalYeast/Pages/Default.aspx. [Accessed: 25-
Dec-2015]. 
[15] D. S. Wishart, C. Knox, A. C. Guo, S. Shrivastava, M. Hassanali, P. Stothard, Z. 
Chang, and J. Woolsey, “DrugBank: a comprehensive resource for in silico drug 
discovery and exploration.,” Nucleic Acids Res., vol. 34, no. Database issue, pp. 
D668–D672, 2006. 
[16] A. G. Warrilow, J. E. Parker, D. E. Kelly, and S. L. Kelly, “Azole Affinity of 
Sterol 14 -Demethylase (CYP51) Enzymes from Candida albicans and Homo 
sapiens,” Antimicrob. Agents Chemother., vol. 57, no. 3, pp. 1352–1360, 2013. 
[17] F. R. Taylor, R. J. Rodriguez, and L. W. Parks, “Relationship Between Antifungal 
Activity and Inhibition of Sterol Biosynthesis in Micanazole, Clotrimazole and 15-
Azasterol,” Anticancer Res, vol. 23, no. 4, pp. 515–521, 1983. 
[18] E. Bilensoy, M. Abdur Rouf, I. Vural, M. Šen, and A. Atilla Hincal, 
“Mucoadhesive, thermosensitive, prolonged-release vaginal gel for clotrimazole: 
β-cyclodextrin complex,” AAPS PharmSciTech, vol. 7, no. 2, pp. E54–E60, Jun. 
2006. 
[19] O. Cristini-Robbe, F. Ruyffelaere, F. Dubart, A. Uwimanimpaye, C. Kinowski, R. 
86 
 
Bernard, C. Robbe-Masselot, I. El Yazidi, and S. Turrell, “Local Drug Delivery 
Strategy for Cancer Treatment: Use of Biocompatible Sol-Gel-Derived Porous 
Materials,” New J. Glas. Ceram., vol. 3, no. 2, pp. 74–79, 2013. 
[20] K. Dhudashia, A. Patel, and C. Patel, “Development and validation of a reversed-
phase HPLC method for simultaneous estimation of clotrimazole and 
beclomethasone dipropionate in lotion and cream dosage form,” Chronicles Young 
Sci., vol. 4, no. 2, p. 102, 2013. 
[21] H. Dressler, Resorcinol: Its Uses and Derivatives. New York: Springer Science + 
Business Media, 1994. 
[22] R. B. Durairaj, Resorcinol-Chemistry Technology & Applications. 2005. 
[23] D. J. Cram, “Cavitands: Organic Hosts with Enforced Cavities,” Science (80-. )., 
vol. 219, no. 4589, 1983. 
[24] “NFPA 2010: Standard for Fixed Aerosol Fire-Extinguishing Systems.” 2015. 
[25] J. Buckingham, Dictionary of natural products. Chapman & Hall, 1994. 
[26] V. Ramamurthy and Y. Inoue, Supramolecular photochemistry : controlling 
photochemical processes. Wiley, 2011. 
[27] J. D. Kopple, S. G. Massry, and K. Kalantar-Zadeh, Nutritional Management of 
Renal Disease. Elsevier Science, 2013. 
[28] K. Drużbicki, E. Mikuli, N. Pałka, S. Zalewski, and M. D. Ossowska-Chruściel, 
“Polymorphism of Resorcinol Explored by Complementary Vibrational 
Spectroscopy (FT-RS, THz-TDS, INS) and First-Principles Solid-State 
Computations (Plane-Wave DFT),” J. Phys. Chem. B, vol. 119, no. 4, pp. 1681–
1695, 2015. 
[29] G. Jemec, J. Revuz, and J. Leyden, Hidradenitis Suppurativa. Springer US, 2006. 
[30] I. A. Guedes, C. S. de Magalhães, and L. E. Dardenne, “Receptor–ligand 
molecular docking,” Biophys. Rev., vol. 6, no. 1, pp. 75–87, 2014. 
87 
 
[31] J. R. Naglik, S. J. Challacombe, and B. Hube, “Candida albicans Secreted Aspartyl 
Proteinases in Virulence and Pathogenesis,” Microbiol. Mol. Biol. Rev., vol. 67, 
no. 3, pp. 400–428, 2003. 
[32] W. L. Chaffin, “Candida albicans Cell Wall Proteins,” Microbiol. Mol. Biol. Rev., 
vol. 72, no. 3, pp. 495–544, 2008. 
[33] M. A. Pfaller, R. N. Jones, S. A. Messer, M. B. Edmond, and R. P. Wenzel, 
“National surveillance of nosocomial blood stream infection due to Candida 
albicans: frequency of occurrence and antifungal susceptibility in the SCOPE 
Program.,” Diagn. Microbiol. Infect. Dis., vol. 31, no. 1, pp. 327–32, May 1998. 
[34] J. D. Sobel, “Pathogenesis and epidemiology of vulvovaginal candidiasis.,” Ann. 
N. Y. Acad. Sci., vol. 544, pp. 547–57, 1988. 
[35] W. Li, D. Yu, S. Gao, J. Lin, Z. Chen, and W. Zhao, “Role of Candida Albicans-
secreted aspartyl proteinases (Saps) in severe early childhood caries,” Int. J. Mol. 
Sci., vol. 15, no. 6, pp. 10766–10779, 2014. 
[36] A. Tavanti, G. Pardini, D. Campa, P. Davini, A. Lupetti, and S. Senesi, 
“Differential expression of secretory aspartyl proteinase genes (SAP1-10) in oral 
Candida albicans isolates with distinct karyotypes,” J. Clin. Microbiol., vol. 42, 
no. 10, pp. 4726–4734, 2004. 
[37] R. de C. Mardegan, M. A. Foglio, R. B. Goncalves, and F. J. Hofling, “Candida 
albicans proteinases,” Braz J Oral Sci., vol. 5, no. 16, pp. 944–952, 2006. 
[38] B. Hube and J. Naglik, “Candida albicans proteinases: resolving the mystery of a 
gene family,” Microbiology, vol. 147, no. 8, pp. 1997–2005, Aug. 2001. 
[39] M. Monod, B. Hube, D. Hess, and D. Sanglard, “Differential regulation of SAP8 
and SAPS, which encode two new members of the secreted aspartic proteinase 
family in Candida albicans,” Microbiology, vol. 144, no. 10, pp. 2731–2737, Oct. 
1998. 
[40] B. Hube, M. Monod, D. A. Schofield, A. J. Brown, and N. A. Gow, “Expression of 
88 
 
seven members of the gene family encoding secretory aspartyl proteinases in 
Candida albicans.,” Mol. Microbiol., vol. 14, no. 1, pp. 87–99, Oct. 1994. 
[41] S. H. Miyasaki, T. C. White, and N. Agabian, “A fourth secreted aspartyl 
proteinase gene (SAP4) and a CARE2 repetitive element are located upstream of 
the SAP1 gene in Candida albicans.,” J. Bacteriol., vol. 176, no. 6, pp. 1702–10, 
Mar. 1994. 
[42] T. C. White, S. H. Miyasaki, and N. Agabian, “Three distinct secreted aspartyl 
proteinases in Candida albicans.,” J. Bacteriol., vol. 175, no. 19, pp. 6126–33, Oct. 
1993. 
[43] M. K. Hostetter, “Adhesins and ligands involved in the interaction of Candida spp. 
with epithelial and endothelial surfaces.,” Clin. Microbiol. Rev., vol. 7, no. 1, pp. 
29–42, Jan. 1994. 
[44] M. Schaller, H. C. Korting, W. Schäfer, J. Bastert, W. Chen, and B. Hube, 
“Secreted aspartic proteinase (Sap) activity contributes to tissue damage in a 
model of human oral candidosis,” Mol. Microbiol., vol. 34, no. 1, pp. 169–180, 
1999. 
[45] B. E. Jackson, K. R. Wilhelmus, and B. Hube, “The role of secreted aspartyl 
proteinases in Candida albicans keratitis,” Investig. Ophthalmol. Vis. Sci., vol. 48, 
no. 8, pp. 3559–3565, 2007. 
[46] M. Schaller, M. Bein, H. C. Korting, S. Baur, G. Hamm, M. Monod, S. Beinhauer, 
and B. Hube, “The secreted aspartyl proteinases Sap1 and Sap2 cause tissue 
damage in an in vitro model of vaginal candidiasis based on reconstituted human 
vaginal epithelium.,” Infect. Immun., vol. 71, no. 6, pp. 3227–34, Jun. 2003. 
[47] E. Pericolini, E. Gabrielli, M. Amacker, L. Kasper, E. Roselletti, E. Luciano, S. 
Sabbatini, M. Kaeser, C. Moser, B. Hube, A. Vecchiarelli, and A. Cassone, 
“Secretory Aspartyl Proteinases Cause Vaginitis and Can Mediate Vaginitis 
Caused by Candida albicans in Mice.,” MBio, vol. 6, no. 3, p. e00724, Jun. 2015. 
89 
 
[48] L. A. Braga-Silva and A. L.S. Santos, “Aspartic Protease Inhibitors as Potential 
Anti-Candida albicans Drugs: Impacts on Fungal Biology, Virulence and 
Pathogenesis,” Curr. Med. Chem., vol. 18, no. 16, pp. 2401–2419, 2011. 
[49] M. Staniszewska, M. Bondaryk, K. Siennicka, J. Piłat, M. Schaller, and W. 
Kurza̧tkowski, “Role of aspartic proteinases in Candida albicans virulence. Part II: 
Expression of SAP1-10 aspartic proteinase during Candida albicans infections in 
vivo,” Postep. Mikrobiol., vol. 51, no. 2, pp. 137–142, 2012. 
[50] B. Didomenico, “Novel antifungal drugs,” Curr. Opin. Microbiol., vol. 2, pp. 509–
515, 1999. 
[51] J. M. Fostel and P. A. Lartey, “Emerging novel antifungal agents,” Ther. Focus, 
vol. 5, no. 1, pp. 25–32, 2000. 
[52] V. Law, C. Knox, Y. Djoumbou, T. Jewison, A. C. Guo, Y. Liu, A. Maciejewski, 
D. Arndt, M. Wilson, V. Neveu, A. Tang, G. Gabriel, C. Ly, S. Adamjee, Z. T. 
Dame, B. Han, Y. Zhou, and D. S. Wishart, “DrugBank 4.0: shedding new light on 
drug metabolism.,” Nucleic Acids Res., vol. 42, no. Database issue, pp. D1091-7, 
Jan. 2014. 
[53] H. J. Smith and Claire Simons, “Proteinase and Peptidase Inhibition-Recent 
Potential Targets for Drug Development,” J. Chem. Inf. Model., vol. 53, no. 9, pp. 
1689–1699, 2013. 
[54] M. Borgers, H. Van den Bossche, and M. De Brabander, “The mechanism of 
action of the new antimycotic ketoconazole.,” Am. J. Med., vol. 74, no. 1B, pp. 2–
8, 1983. 
[55] C. Eil, “Ketoconazole binds to the human androgen receptor.,” Horm. Metab. Res., 
vol. 24, no. 8, pp. 367–70, 1992. 
[56] M. M. Al-shalalfeh, A. T. Onawole, A. Saleh, and A. A. Al-saadi, “Spherical silver 
nanoparticles as substrates in surface-enhanced Raman spectroscopy for enhanced 
characterization of ketoconazole,” Mater. Sci. Eng. C, vol. 76, pp. 356–364, 2017. 
90 
 
[57] L. L. Patton, A. J. Bonito, D. A. Shugars, and C. Hill, “A systematic review of the 
effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal 
candidiasis in HIV-positive patients,” Oral Surg Oral Med Oral Pathol Oral 
Radiol Endod, vol. 92, pp. 170–179, 2001. 
[58] P. R. Sawyer, R. N. Brogden, R. M. Pinder, T. M. Speight, and C. S. Avery, 
“Clotrimazole : A Review of its Antifungal Activity and Therapeutic Efficacy,” 
Drugs, vol. 9, pp. 424–447, 1975. 
[59] C. A. Lipinski, “Lead- and drug-like compounds: The rule-of-five revolution,” 
Drug Discov. Today Technol., vol. 1, no. 4, pp. 337–341, 2004. 
[60] C. A. Lipinski, “Drug-like properties and the causes of poor solubility and poor 
permeability,” J. Pharmacol. Toxicol. Methods, vol. 44, no. 1, pp. 235–249, 2000. 
[61] J. H. Rex, T. J. Walsh, J. D. Sobel, S. G. Filler, P. G. Pappas, W. E. Dismukes, and 
J. E. Edwards, “Practice guidelines for the treatment of candidiasis,” Clin. Infect. 
Dis., vol. 38, no. 4, pp. 161–189, 2004. 
[62] P. G. Pappas, C. A. Kauffman, D. Andes, D. K. Benjamin, Jr., T. F. Calandra, J. E. 
Edwards, Jr., S. G. Filler, J. F. Fisher, B. Kullberg, L. Ostrosky‐ Zeichner, A. C. 
Reboli, J. H. Rex, T. J. Walsh, and J. D. Sobel, “Clinical Practice Guidelines for 
the Management of Candidiasis: 2009 Update by the Infectious Diseases Society 
of America,” Clin. Infect. Dis., vol. 48, no. 5, pp. 503–535, 2009. 
[63] I. B. Obot, N. O. Obi-Egbedi, and S. A. Umoren, “Experimental and theoretical 
investigation of clotrimazole as corrosion inhibitor for aluminium in hydrochloric 
acid and effect of iodide ion addition,” Der Pharma Chem., vol. 1, no. 1, pp. 151–
166, 2009. 
[64] T. A. Saleh, M. M. Al-shalalfeh, A. T. Onawole, and A. A. Al-saadi, “Ultra-trace 
detection of methimazole by surface-enhanced Raman spectroscopy using gold 
substrate,” Vib. Spectrosc., vol. 90, pp. 96–103, 2017. 
[65] T. A. Saleh, M. M. Al-Shalalfeh, and A. A. Al-Saadi, “Graphene Dendrimer-
91 
 
stabilized silver nanoparticles for detection of methimazole using Surface-
enhanced Raman scattering with computational assignment,” Sci. Rep., vol. 6, no. 
May, p. 32185, 2016. 
[66] E. Rodríguez, A. Encinas, F. J. Masa, and F. J. Beltrán, “Influence of resorcinol 
chemical oxidation on the removal of resulting organic carbon by activated carbon 
adsorption,” Chemosphere, vol. 70, pp. 1366–1374, 2008. 
[67] J. Z. Zhang and C. J. Fischer, “A simplified resorcinol method for direct 
spectrophotometric determination of nitrate in seawater,” Mar. Chem., vol. 99, pp. 
220–226, 2006. 
[68] A. Husain, M. Maaz, K. A. Ansari, A. Ahmad, and M. Rashid, “Synthesis and 
microbiological evaluation of mannich bases derived from 4,6-diacetylresorcinol,” 
vol. 3, no. 5, pp. 18–20, 2010. 
[69] J. M. Robertson, “The Structure of Resorcinol A Quantitative X-Ray 
Investigation,” Proc. R. Soc. A Math. Phys. Eng. Sci., vol. 157, no. 890, pp. 79–99, 
1936. 
[70] J. M. Robertson and  a. R. Ubbelohde, “A New Form of Resorcinol. I. Structure 
Determination by X-Rays,” Proc. R. Soc. A Math. Phys. Eng. Sci., vol. 167, no. 
928, pp. 122–135, 1938. 
[71] Y. Ebisuzaki, L. H. Askari,  a. M. Bryan, and M. F. Nicol, “Phase transitions in 
resorcinal,” J. Chem. Phys., vol. 87, p. 6659, 1987. 
[72] T. Dunn, “Free-Jet Spectra and structure of O-, m-, and p-Dihydroxybenzenes,” 
Chem. Phys. Lett., vol. 121, pp. 453–457, 1985. 
[73] M. Gerhards, W. Perl, and K. Kleinermanns, “Rotamers and vibrations of 
resorcinol obtained by spectral hole burning,” Chem. Phys. Lett., vol. 240, no. 
July, pp. 506–512, 1995. 
[74] S. Melandri, G. Maccaferri, W. Caminati, and P. G. Favero, “Conformational 
equilibrium in resorcinol by means of the free-jet absorption millimeter wave 
92 
 
spectrum,” Chem. Phys. Lett., vol. 256, no. 4–5, pp. 513–517, Jul. 1996. 
[75] G. Myszkiewicz, W. L. Meerts, C. Ratzer, and M. Schmitt, “Structure 
determination of resorcinol rotamers by high-resolution UV spectroscopy,” 
ChemPhysChem, vol. 6, pp. 2129–2136, 2005. 
[76] M. Gerhards, M. Schiwek, C. Unterberg, and K. Kleinermanns, “OH stretching 
vibrations in aromatic cations: IR/PIRI spectroscopy,” Chem. Phys. Lett., vol. 297, 
no. December, pp. 515–522, 1998. 
[77] G. M. Day, S. L. Price, and M. Leslie, “Elastic Constant Calculations for 
Molecular Organic Crystals,” Cryst. Growth Des., vol. 1, no. 1, pp. 13–27, 2000. 
[78] P. Claudio and T.-K. Ha, “A theoretical study of conformations and rotational 
barriers in Dihydroxybenzenes,” vol. 204, pp. 337–351, 1990. 
[79] Z. Berkovitch-Yellin, “Toward an ab Initio Derivation of Crystal Morphology,” J 
Am Chem Soc, vol. 107, no. 14, pp. 8239–8253, 1985. 
[80] J. Chatchawalsaisin, J. Kendrick, S. C. Tuble, and Jamshed Anwar., “An 
Optimized force field for crystalline phases of resorcinol,” CrystEngComm, 2008. 
[81] D. Penot, Mathieu, and J. Paul, “The Raman Spectra of Alhpa and Beta 
Resorcinols,” pp. 2–3, 1955. 
[82] A. Hidalgo and C. Otero, “Spectres d ’ absorption ~~ aro ~ ge du ph6nol et des 
diphbnols,” vol. 16, no. 1943, 1960. 
[83] J. H. S. Green, “Vibrational spectra of benzene derivatives - VI. p-disubstituted 
compounds,” Spectrochim. Acta, vol. 26A, no. 1968, pp. 1503–1513, 1970. 
[84] S. E. Blanco, M. C. Almandoz, and F. H. Ferretti, “Determination of the 
overlapping pKa values of resorcinol using UV-visible spectroscopy and DFT 
methods,” Spectrochim. Acta - Part A Mol. Biomol. Spectrosc., vol. 61, pp. 93–
102, 2005. 
[85] R. Rudyk, M. a. . Molina, M. . Gómez, S. . Blanco, and F. . Ferretti, “Solvent 
93 
 
effects on the structure and dipole moment of resorcinol,” J. Mol. Struct. 
THEOCHEM, vol. 674, no. 1–3, pp. 7–14, Apr. 2004. 
[86] W. Wilson, “The Vapor Phase infrared spectra of hydroquinone, pyrocatechol, and 
resorcinol,” 1974. 
[87] P. Imhof, R. Brause, and K. Kleinermanns, “Determination of Ground State 
Vibrational Frequencies of Jet-Cooled Resorcinol by Means of Dispersed 
Fluorescence Spectroscopy and ab Initio Calculations,” J. Mol. Spectrosc., vol. 
211, no. 1, pp. 65–70, Jan. 2002. 
[88] G. N. R. Tripathi, “Crystal spectra and vibrational assignments in α-resorcinol,” J. 
Chem. Phys., vol. 74, p. 250, 1981. 
[89] K. Hattori, S. I. Ishiuchi, D. L. Howard, H. G. Kjaergaard, M. Fujii, D. L. Howard, 
and H. G. Kjaergaard, “Vibrational OH-stretching overtone spectroscopy of jet-
cooled resorcinol and hydroquinone rotamers,” J. Phys. Chem. A, vol. 111, pp. 
6028–6033, 2007. 
[90] G. E. S. M. J. Frisch, G. W. Trucks, H. B. Schlegel, B. M. M. A. Robb, J. R. 
Cheeseman, G. Scalmani, V. Barone, H. P. H. G. A. Petersson, H. Nakatsuji, M. 
Caricato, X. Li, M. H. A. F. Izmaylov, J. Bloino, G. Zheng, J. L. Sonnenberg, T. 
N. M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, J. Y. Honda, O. 
Kitao, H. Nakai, T. Vreven, J. A. Montgomery, E. B. J. E. Peralta, F. Ogliaro, M. 
Bearpark, J. J. Heyd, J. N. K. N. Kudin, V. N. Staroverov, T. Keith, R. Kobayashi, 
J. T. K. Raghavachari, A. Rendell, J. C. Burant, S. S. Iyengar, J. B. C. M. Cossi, N. 
Rega, J. M. Millam, M. Klene, J. E. Knox, R. E. S. V. Bakken, C. Adamo, J. 
Jaramillo, R. Gomperts, J. W. O. O. Yazyev, A. J. Austin, R. Cammi, C. Pomelli, 
G. A. V. R. L. Martin, K. Morokuma, V. G. Zakrzewski, A. D. D. P. Salvador, J. J. 
Dannenberg, S. Dapprich, J. C. O. Farkas, J. B. Foresman, J. V. Ortiz, and  and D. 
J. Fox, “Gaussian 09, Revision D.01,” Gaussian, Inc. Wallingford CT. 2013. 
[91] M. H. Jamróz, “Vibrational energy distribution analysis (VEDA): Scopes and 




[92] T. K. R. Dennington  J. Millam, R. Dennington, T. Keith, and J. Millam, 
“GaussView,” vol. 131 TS-, no. 37. Semichem Inc, Shawnee Mission KS, 2009. 
[93] A. A. Al-Saadi and J. Laane, “Ab initio and DFT calculations for the structure and 
vibrational spectra of cyclopentene and its isotopomers,” J. Mol. Struct., vol. 830, 
no. 1–3, pp. 46–57, 2007. 
[94] H. M. Berman, J. D. Westbrook, Z. Feng, G. L. Gilliland, T. N. Bhat, H. Weissig, 
I. N. Shindyalov, P. E. Bourne, T. Battistuz, T. N. Bhat, W. F. Bluhm, E. Philip, K. 
Burkhardt, Z. Feng, G. L. Gilliland, L. Iype, S. Jain, P. Fagan, J. Marvin, D. 
Padilla, V. Ravichandran, N. Thanki, H. Weissig, and J. D. Westbrook, “The 
Protein Data Bank.,” Nucleic Acids Res., vol. 28, no. 1, pp. 235–242, 2000. 
[95] G. J. Kleywegt and T. A. Jones, “Phi/Psi-chology: Ramachandran revisited,” 
Structure, vol. 4, no. 12, pp. 1395–1400, 1996. 
[96] T. Knudsen, Bjarne Knudsen, “CLC Drug Discovery Workbench.” pp. 1–367, 
2016. 
[97] D. S. BIOVIA, “Discovery Studio Modeling Environment.” Dassault Systèmes, 
San Diego, 2015. 
[98] G. Roussy and F. Michel, “Spectres de rotation de la molécule de chlorobenzéne,” 
J. Mol. Struct., vol. 30, no. 2, pp. 399–407, Feb. 1976. 
[99] R. D. Johnson, “NIST Computational Chemistry Comparison and Benchmark 
Database.” [Online]. Available: http://cccbdb.nist.gov/. [Accessed: 28-May-2017]. 
[100] Kuchitsu, Landolt-Bornstein: Group II: Atomic and Molecular Physics Volume 15: 
Structure Data of Free Polyatomic Molecules. Berlin: Springer-Verlag, 1987. 
[101] R. Ramasamy, “Vibrational spectroscopic studies of Imidazole,” Armen. J. Phys., 
vol. 8, no. 1, pp. 51–55, 2015. 
[102] R. Ramasamy and B. Dhanaraj, “Vibrational Spectroscopic Studies of Toluene,” J. 
95 
 
Int. Acad. Res. Multidiscip., vol. 2, no. 4, pp. 234–240, 2014. 
[103] Z. El Adnani, M. Mcharfi, M. Sfaira, M. Benzakour, A. T. Benjelloun, and M. Ebn 
Touhami, “DFT theoretical study of 7-R-3methylquinoxalin-2(1H)-thiones (RH; 
CH3; Cl) as corrosion inhibitors in hydrochloric acid,” Corros. Sci., vol. 68, pp. 
223–230, 2013. 
[104] S. B. Ade, N. V. Shitole, and S. M. Lonkar, “Antifungal drug’s used as metal 
corrosion inhibitor in various acid medium,” Int. J. ChemTech Res., vol. 6, no. 7, 
pp. 3642–3650, 2014. 
[105] B. Hube, “Candida albicans secreted aspartyl proteinases.,” Curr. Top. Med. 
Mycol., vol. 7, no. 1, pp. 55–69, Dec. 1996. 
[106] F. M. Klis, G. J. Sosinska, P. W. J. De Groot, and S. Brul, “Covalently linked cell 
wall proteins of Candida albicans and their role in fitness and virulence,” FEMS 
Yeast Res., vol. 9, no. 7, pp. 1013–1028, 2009. 
[107] P. Manivannan and G. Muralitharan, “Molecular modeling of abc transporter 
system — permease proteins from Microcoleus chthonoplastes PCC 7420 for 
effective binding against secreted aspartyl proteinases in Candida albicans — A 
therapeutic intervention,” Interdiscip. Sci. Comput. Life Sci., vol. 6, no. 1, pp. 63–
70, 2014. 
[108] S. M. Cutfield, E. J. Dodson, B. F. Anderson, P. C. Moody, C. J. Marshall, P. A. 
Sullivan, and J. F. Cutfield, “The crystal structure of a major secreted aspartic 
proteinase from Candida albicans in complexes with two inhibitors.,” Structure, 
vol. 3, no. 11, pp. 1261–71, Dec. 1995. 
[109] T. Lengauer and M. Rarey, “Computational methods for biomolecular docking,” 
Curr. Opin. Struct. Biol., vol. 6, no. 3, pp. 402–406, 1996. 
[110] J. C. Sundaramurthi, S. Kumar, K. Silambuchelvi, and L. E. Hanna, “Molecular 
docking of azole drugs and their analogs on CYP121 of Mycobacterium 
tuberculosis.,” Bioinformation, vol. 7, no. 3, pp. 130–3, 2011. 
96 
 
[111] G. J. Kleywegt and T. A. Jones, “Phi/Psi-chology,” Structure, vol. 4, no. 12, pp. 
1395–1400, 1996. 
[112] Q. Zhu, A. G. Shtukenberg, D. J. Carter, T. Yu, J. Yang, M. Chen, P. Raiteri, A. R. 
Oganov, B. Pokroy, I. Polishchuk, P. J. Bygrave, G. M. Day, A. L. Rohl, M. E. 
Tuckerman, and B. Kahr, “Resorcinol Crystallization from the Melt: A New 
Ambient Phase and New ‘ Riddles ,’” J Am Chem Soc, vol. 138, pp. 4881–4889, 
2016. 
[113] S. Pathak, J. Alonso, M. Schimpl, K. Rafie, D. E. Blair, V. S. Borodkin, A. W. 
Schüttelkopf, O. Albarbarawi, and D. M. F. van Aalten, “The active site of O-
GlcNAc transferase imposes constraints on substrate sequence.,” Nat. Struct. Mol. 
Biol., vol. 22, no. 9, pp. 744–750, Aug. 2015. 
[114] S. Horowitz and R. C. Trievel, “Carbon-oxygen hydrogen bonding in biological 
structure and function.,” J. Biol. Chem., vol. 287, no. 50, pp. 41576–82, Dec. 2012. 
[115] M. E. Bunnage, A. M. Gilbert, L. H. Jones, and E. C. Hett, “Know your target, 
know your molecule,” Nat. Chem. Biol., vol. 11, no. 6, pp. 368–372, 2015. 
[116] P. S. Miller and A. R. Aricescu, “Crystal structure of a human GABAA receptor,” 
Nature, vol. 512, no. 7514, pp. 270–275, Jun. 2014. 
[117] S. Urig, K. Fritz-Wolf, R. Réau, C. Herold-Mende, K. Tóth, E. Davioud-Charvet, 
and K. Becker, “Undressing of Phosphine Gold(I) Complexes as Irreversible 
Inhibitors of Human Disulfide Reductases,” Angew. Chemie Int. Ed., vol. 45, no. 
12, pp. 1881–1886, Mar. 2006. 
[118] L. H. Duntas, “The Role of Selenium in Thyroid Autoimmunity and Cancer,” 
Thyroid, vol. 16, no. 5, pp. 455–460, May 2006. 
[119] B. M. Selenius M, Rundlöf AK, Olm E, Fernandes AP, “Selenium and the 
selenoprotein thioredoxin reductase in the prevention, treatment and diagnostics of 
cancer.,” Antioxid. Redox. Signal., vol. 12, no. 7, pp. 867–80, 2010. 
[120] Q. Cheng, T. Sandalova, Y. Lindqvist, and E. S. J. Arnér, “Crystal structure and 
97 
 
catalysis of the selenoprotein thioredoxin reductase 1.,” J. Biol. Chem., vol. 284, 
no. 6, pp. 3998–4008, Feb. 2009. 
[121] P. K. Bhabak, J. B. Bhuyan, and G. Mugesh, “Bioinorganic and medicinal 
chemistry: aspects of gold(I)-protein complexes,” Dalt. Trans., vol. 40, pp. 2099–
2111, 2011. 
[122] J. Y. Y. Shao, L. Fusti-Molnar, Y. Jung, J. Kussmann, C. Ochsenfeld, S.T. Brown, 
A.T.B. Gilbert, L.V. Slipchenko, S.V. Levchenko, D.P. O’Neill, R.A. DiStasio Jr., 
R.C. Lochan, T. Wang, G.J.O. Beran, N.A. Besley, J.M. Herbert, C.Y. Lin, T. Van 
Voorhis, S.H. Chie, “Spartan’10 build 1.0.1.” Wavefunction Inc., Irvine CA, p. 
Irvine CA, 2011. 
[123] T. Shoeib, D. W. Atkinson, and B. L. Sharp, “Structural analysis of the anti-
arthritic drug Auranofin: Its complexes with cysteine, selenocysteine and their 
fragmentation products,” Inorganica Chim. Acta, vol. 363, no. 1, pp. 184–192, 
2010. 
[124] A. T. Maynard, C. D. Roberts, M. Drive, N. Carolina, and U. States, “Quantifying, 
Visualizing, and Monitoring Lead Optimization,” 2016. 
[125] F. Z. Dorwald, Lead Optimisation for Medicinal Chemists. 2012. 
[126] C. Bohl, D. Miller, J. Chen, C. Bell, and J. Dalton, “Structural Basis for 
Accommodation of Nonsteroidal Ligands in the Androgen Receptor,” J. Biol. 
Chem., vol. 280, no. 45, pp. 37747–37754, 2005. 
[127] S. Chacko, E. A. Padlan, S. Portolano, S. M. McLachlan, and B. Rapoport, 
“Structural Studies of Human Autoantibodies: CRYSTAL STRUCTURE OF A 
THYROID PEROXIDASE AUTOANTIBODY FAB,” J. Biol. Chem., vol. 271, 
no. 21, pp. 12191–12198, May 1996. 
[128] S. C. Lovell, I. W. Davis, W. B. Adrendall, P. I. W. de Bakker, J. M. Word, M. G. 
Prisant, J. S. Richardson, and D. C. Richardson, “Structure validation by C alpha 
geometry: phi,psi and C beta deviation,” Proteins-Structure Funct. Genet., vol. 50, 
98 
 
no. August 2002, pp. 437–450, 2003. 
[129] O. Trott and A. Olson, “AutoDock Vina: improving the speed and accuracy of 
docking with a new scoring function, efficient optimization and multithreading,” J. 
Comput. Chem., vol. 31, no. 2, pp. 455–461, 2010. 
[130] S. Dallakyan and A. J. Olson, “Small-Molecule Library Screening by Docking 




















Name    :Abdulmujeeb Toluwase Onawole 
Nationality   :Nigerian 
Date of Birth   :5/14/1989 
Email    :atonawole@gmail.com 
Address   :10, Aruba, Sabo, Sagamu, Ogun state, Nigeria 
Academic Background :B. Tech (Pure and Applied Chemistry), Ladoke Akintola 
University of Technology, Ogbomoso, Nigeria (2011); MSc. (Chemistry), King Fahd 
University of Petroleum and Minerals, Dhahran, Saudi Arabia (2017) 
Publications: 
[1] A. T. Onawole, A. F. Al-Ahmadi, Y. S. Mary, C. Y. Panicker, N. Ullah, S. Armaković, 
S. J. Armaković, C. V. Alsenoy, and A. A. Al-Saadi, “Conformational, vibrational and 
DFT studies of a newly synthesized arylpiperazine-based drug and evaluation of its 
reactivity towards the human GABA receptor,” J. Mol. Struct., vol. 1147, pp. 266–280, 
2017. 
[2] A. A. A. Seliman, M. Altaf, A. T. Onawole, S. Ahmad, M. Y. Ahmed, A. A. Al-Saadi, S. 
Altuwaijri, G. Bhatia, J. Singh, and A. A. Isab, “Synthesis, X-ray structures and 
anticancer activity of gold(I)-carbene complexes with selenones as co-ligands and their 
molecular docking studies with thioredoxin reductase,” J. Organomet. Chem., vol. 848, 
pp. 175–183, 2017. 
100 
 
[3] T. A. Saleh, M. M. Al-shalalfeh, A. T. Onawole, and A. A. Al-saadi, “Ultra-trace 
detection of methimazole by surface-enhanced Raman spectroscopy using gold 
substrate,” Vib. Spectrosc., vol. 90, pp. 96–103, 2017. 
[4] A. T. Onawole, K. O. Sulaiman, R. O. Adegoke, and T. U. Kolapo, “Identification of 
potential inhibitors against the Zika virus using consensus scoring,” J. Mol. Graph. 
Model., vol. 73, pp. 54–61, 2017. 
[5] M. M. Al-shalalfeh, A. T. Onawole, A. Saleh, and A. A. Al-saadi, “Spherical silver 
nanoparticles as substrates in surface-enhanced Raman spectroscopy for enhanced 
characterization of ketoconazole,” Mater. Sci. Eng. C, vol. 76, pp. 356–364, 2017. 
[6] K. O. Sulaiman and A. T. Onawole, “Quantum chemical evaluation of the corrosion 
inhibition of novel aromatic hydrazide derivatives on mild steel in hydrochloric acid,” 
Comput. Theor. Chem., vol. 1093, pp. 73–80, 2016. 
 
Conference Proceedings: 
[1] A. T. Onawole and A. A. Al-Saadi, “Computational study of the conformations and 
molecular docking of the anti-fungal drug clotrimazole in aiding drug delivery via 
nanostructured lipid carriers,” Poster session presented at: Kuwait International 
Nanotechnology Conference & Exhibitions, 2016 Feb 9-11;  Regency Hotel, State of 
Kuwait. 
 
 
